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ABSTRACT 
 Age-related Macular Degeneration (AMD) is the leading cause of irreversible 
vision loss among elderly people in developed countries. The non-neovascular or “dry” 
form of AMD accounts for 85%, whereas the neovascular or “wet” accounts for 15%, of 
all cases. There are no effective treatments for dry AMD mainly because the molecular 
mechanisms that lead to the development and progression of AMD are not fully 
understood. Similarly, while wet AMD is being treated with antibodies against vascular 
endothelial growth factor (VEGF), the underlying cause that results in the development 
of wet AMD remains elusive. 
Cytosolic accumulation of nuclear-DNA (nDNA) fragments has been found to 
trigger inflammation and mediate the development of multiple diseases. Because 
inflammation plays a pivotal role in AMD pathogenesis, we thus investigated if 
accumulation of cytosolic nDNA also contributes to AMD. 
Our data show that cytosolic nDNA is enriched in macular retinal pigment 
epithelium (RPE) cells of AMD patients. To study the effect of cytosolic nDNA on RPE 
	
	 vii 
cells, we mimicked this pathology by deleting the lysosomal endonuclease Dnase2a, 
which is responsible for degrading DNA fragments, using CRISPR/Cas9. This resulted in 
cytosolic accumulation of nDNA in cultured primary human RPE cells as well as in the 
RPE cell line ARPE-19. Importantly, both RPE cell types with Dnase2a loss became 
senescent and secreted higher levels of VGEF and pro-inflammatory cytokines compared 
to control. These effects were mediated by the DNA sensor STING and mTOR pathway. 
Additionally, similar to other senescent cells, these senescent RPE cells secreted factors 
that acted in a paracrine manner turning otherwise healthy RPE cells into senescent cells 
that start secreting VEGF as well as pro-inflammatory cytokines. Finally, we found that 
mice with Dnase2a deletion develop features of AMD-like retinopathy, including drusen-
like deposits, thickened Bruch’s membrane, RPE damage, photoreceptor atrophy, and 
reduced electroretinogram.  
The pleiotropic downstream effects of cytosolic accumulation of nDNA in RPE 
cells, which are consistent with the complex AMD pathology, suggest that this 
phenomenon contributes to the pathogenesis of AMD and thereby opens new 
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CHAPTER ONE. INTRODUCTION 
Anatomy of the eye 
 
The mammalian eye is composed of three layers, each of which has one or more 
important components1. These three layers are (Fig. 1): 
1. The external layer, which is formed by the sclera (the white part of the eye) and 
the cornea (the clear front surface of the eye)1.  
2. The intermediate layer, the uvea, which is divided into two parts: anterior (iris 
and ciliary body) and posterior (choroid). The choroid is primarily a vascular 
structure that supports the outer retina with oxygen and nourishment1. 








Figure 1. Anatomy of the eye.  
Cross section of the human eyeball viewed from above showing the different pats of the 





Anatomy of the retina 
	
The human retina is composed of a neurosensory retina and a retinal pigment 
epithelium layer (Fig. 2). The neurosensory retina has three layers of cell bodies and two 
layers of synapses2. The layers that contain cell bodies, from outside to inside of the 
retina, are (Fig. 2):  
1. The outer nuclear layer (ONL), which contains cell bodies of the photoreceptors 
(rods and cons)2.   
2. The inner nuclear layer (INL), which contains cell bodies of the bipolar, 
horizontal and amacrine cells2. 
3. The ganglion cell layer, which mainly contains cell bodies of the ganglion cells, 
the exons of which form the optic nerve2.  
These three nerve cell layers are divided by two neuropils where synaptic contacts occur 
(Fig. 2). These two neuropils are: 
1. The outer plexiform layer (OPL), which consists of synapses between rod and 
cons, and bipolar and horizontal cells2.  
2. The inner plexiform layer (IPL), which consists of synapses between bipolar cells 




















Figure 2. Layers of the human retina. 
A 3-D block of a portion of human retina showing the different layers of the retina. 






Figure 3. Layers of the human retina. 





The Retinal Pigment Epithelium (RPE)  
 
The retinal pigment epithelium (RPE) is a monolayer of hexagonal cells derived 
from the optic vesicle neuroepithelium3,4. It is located between the neurosensory retina 
and the choroid (Fig. 4). RPE cells are pigmented because they are packed with 
melanosomes containing melanin pigment, especially in apical side of the cytoplasm. On 


















Figure 4. Light micrograph of the human retinal pigment epithelium (left) with the 
choroids above and the retina below. Cartoon of the retinal pigment epithelium (RPE) 
(right) aligned alongside the micrograph. CC, choirocapillaris; BM, Bruchs membrane; 
RPE, retinal pigment epithelium; ap, apical processes; os, outer segments; C, cones; R, 






The apical surface of RPE cells contains microvilli that extend to envelop the 
outer segments of rods and cons allowing for a unique functional relationship with the 
photoreceptor cells3,4 (Fig. 4).  The lateral membranes of RPE provide sites for cell-cell 
adhesion and cell communication through tight, adherence and gap junctions and play an 
important role in maintaining cell polarity. Through its basal membrane, the RPE is in 
contact with Bruch’s membrane, a highly specialized five-layered extracellular matrix 
that forms the basis for mediating the interaction between RPE and blood flow in the 
fenestrated vessels of the choroid (the choriocapillaris). The RPE basal membrane is 
embellished with complex infoldings that play a key role in transport between RPE and 



















Figure 5. Diagram of the outer retina illustrating the polarized nature of the RPE 
monolayer and its relationship to the photoreceptor inner and outer segments, Bruch’s 
membrane and the choriocapillaris. The RPE shows apical microvilli, tight junctions and 
basal/lateral infolding. The endothelial cells of the choroid are fenestrated. Obtained with 





The RPE has several functions that are critical for supporting photoreceptor health 
and integrity and for the visual function. Therefore, defects in RPE functions or 
interaction with photoreceptors lead to multiple retinal diseases4. The main RPE 
functions are4 (Fig. 6):  
 
	
Figure 6. Summary of retinal pigment epithelium (RPE) functions. PEDF, pigment 
epithelium-derived growth factor; VEGF, vascular epithelium growth factor; Epithel, 





1. Absorption of light. Similar to a camera, the heavily pigmented RPE cells absorb 
scattered light to improve the quality of the optical system of the eye 33.  
2. Epithelial transport. The RPE provides a highly selective transport system from 
the blood in the choroid to the retina to supply nutrients to the photoreceptors. It 
also controls the ion homeostasis in the subretinal space (i.e., the space between 
the neurosensory retina and RPE) and eliminates water and metabolites from the 
retina by transporting them to the choroid.   
3. Spatial buffering of ions in the subretinal space. In addition to the 
transepithelial transport mentioned above, the RPE stabilizes the ion homeostasis 
in the subretinal space by compensating for fast occurring changes in the ion 
composition in this space, which is analogous to the ability of glia cells for spatial 
buffering of ions.  
4. Visual cycle. The RPE plays a crucial role in the visual cycle, which maintains 
the visual function and adapts to different visual needs. RPE cells are the location 
for re-isomerization and storage of 11-cis retinal, a chromophore that is critical 
for the visual cycle.   
5. Phagocytosis of photoreceptor outer membranes. Photoreceptor outer 
segments (POS) are exposed to constant destruction because of photo-oxidative 
damage. POS thus are continuously renewed by shedding their destroyed tips. 
Then, RPE cells phagocytose and digest these segments to maintain the proper 




6. Secretion. The RPE secrets several factors and signaling molecules from its 
apical and basal sides to communicate with the neighboring photoreceptors, 
endothelial cells, immune cells, and other cell types. For instance, the RPE secrets 
vascular endothelial growth factor (VEGF), fibroblast growth factors (FGF-1, 
FGF-2, and FGF-5), transforming growth factor-β (TGF-β), several interleukins 
(IL-6, IL-8, and other ILs), many immune modulatory factors, and others.  
 
The macula is an oval-shaped area near the center of the human, and some other 
mammalian, retina (Fig. 1). It is responsible for the central, detailed, and color vision. 
The macula has a diameter of 5.5 mm and consists of perifovea, parafovea, foveal slope, 
and the foveal pit, which is the center of the fovea and has a high concentration of cone 






Age-related Macular Degeneration (AMD) 
 
Age-related Macular Degeneration (AMD) is the primary leading cause of 
irreversible vision loss in the Western world and the third cause of blindness 
worldwide7,8. The prevalence of AMD increases with age. Therefore, as a consequence of 
the increased aging populations, the number of people affected by AMD is estimated to 
be 288 million by 20407,8.  
AMD causes damage to the macula and presents in two main forms (Figure 7):  
1.   Non-neovascular, non-exudative “dry” AMD, which accounts for 85-90% of 
all AMD cases. Dry AMD is characterized by accumulation of extracellular 
deposits, termed drusen, under the RPE and neurosensroy retina, as well as 
degeneration of the RPE, photoreceptors, and even the choroidal vasculature7.  
2. Neovascular, exudative “wet” AMD, which accounts for 10-15% of all AMD 
cases. Wet AMD is characterized by neovascularization arising from the choroid 











Figure 7. Dry and wet AMD.  
A schematic showing the normal macula (left), dry AMD with drusen (middle), and wet 





There are no effective treatments for dry AMD mainly because the molecular 
mechanisms that lead to the development and progression of AMD are not fully 
understood7,9. Similarly, while wet AMD is being effectively treated with antibodies 
against vascular endothelial growth factor (VEGF), a potent endothelial cell mitogen, the 
underlying cause that results in the development of wet AMD remains elusive7,9. 
Therefore, there is an overwhelming importance to study the pathogenesis of this disease 
in order to develop effective treatments.  
Although there is no a unifying hypothesis that can explain how AMD starts and 
progresses, it is known that multiple risk factors and biological processes are involved in 
AMD pathogenesis7. Risk factors for AMD include advanced age, which is the biggest 
risk factor, having a family history of AMD, cigarette smoking, hypertension, elevated 
cholesterol, obesity, and other genetic as well as environmental factors7,9-14.  
Several processes, including oxidative damage, lipid deposition, lipofuscin 
accumulation, amyloid accumulation, and increased cell death in the retina have also 
been shown to play a role in AMD9,15. In addition, inflammation has been recognized 
widely as a central player in all stages of AMD and multiple studies indicate that drusen 
are sites of immune complex formation in AMD pathogenesis9,316-29. For instance, many 
cytokines, such as IL-6, IL-8, IL-1β, IL-12, and TNF-α, are strongly associated with 
AMD7,9,17,18,24-28,30. In addition, the complement system plays an important role in AMD 
pathogenesis and alterations in genes encoding complement factors are strongly 
associated with AMD. These include, for example, genes of complement components 2 




CFI)7,9,19-23. Other central immune system components, such as the chemokine receptor 
CX3CR1, chemokine CCL-2, and monocyte chemotactic protein 1, MCP-1, are also 
associated with genetic susceptibility to AMD7,9,18. 
Many researchers suggest that RPE cell injury is the primary event in AMD9. 
Multiple factors can induce inflammation in RPE cells in AMD9,18. A previous report 
from our lab showed that mitochondria DNA (mtDNA) that is exposed in the cytosol 
induces the secretion of IL-6 and IL-8, which are strongly associated with AMD, in RPE 
cells31. Interestingly, this effect is sequence-independent (Fig. 8) indicating that nuclear 











Figure 8. mtDNA fragments induces cytokine response in a sequence-independent 
manner. IL-6 and IL-8 secretion from ARPE-19 cells 48 hours post-transfection with 
1μg/ml of 2-kb mtDNA fragments of different sequences but similar sizes (schematic). 





In fact, our data shows that transfecting RPE nDNA in RPE cells also induces the 
secretion of IL-6 and IL-8 (Fig. 9). This is consistent with multiple studies showing that 
accumulation of self-DNA in the cytosol can induce inflammation and contributes to 
inflammatory conditions. For instance, this accumulation can lead to chronic 
polyarthritis, resembling human rheumatoid arthritis, and to production of immune 
cytokines, including TNF-α, IL-6, IL-1β, CXCL10 and type I IFNs, and autoantibodies 
(rheumatoid factor and anti-double-stranded DNA [dsDNA]) in mice32,33. In addition, 
accumulation of damaged DNA induces infiltration of inflammatory cells and elevation 
in the expression of inflammatory cytokines in the heart followed by severe myocarditis 
and dilated cardiomyopathy that lead to increased mortality in mice34. Moreover, 
accumulation of DNA fragments has been shown to result in suppression of the thyroid 
cell function35. Furthermore, mutations in the nucleases that remove excess and damaged 
DNA from the cell can lead to nephritis in mice and autoimmune diseases, including 























Figure 9. Nuclear DNA (nDNA) fragments induces cytokine response. IL-6 and IL-8 






Under steady-state conditions, nDNA replication debris and damaged nDNA are 
exported in a controlled manner from the nucleus to the cytosol for degradation in the 
lysosome42-44. The nuclear-to-autophagosome and the autophagosome-to-lysosome 
transport pathways are both crucial for proper disposal of nDNA fragments42. However, 
this process can be overwhelmed, leading to cytosolic accumulation of nDNA fragments, 
due to one or more of the following reasons:  
1. Increased de novo production of nDNA fragments (i.e., aberrant oversupply), such 
as in the case of increased levels of nDNA damage or defects in DNA repair43,45.  
2. Disruption of the nuclear envelope’s integrity, which allows accelerated “leakage” 
of nDNA fragments to the cytosol. For example, downregulation of lamin B1 in 
the nuclear envelop can facilitate chromatin fragments budding off the nucleus to 
the cytosol to be processed by the autophagy-lysosomal pathway46. 
3. Defective autophagy machinery.  
4.   Impairment in the DNA degradation machineries, which leads to defects in the 
disposal of DNA within the lysosomal compartments. For example, loss of 
Dnase2a, a lysosomal endonuclease that is responsible for degradation of DNA 
fragments, leads to cytosolic accumulation of nDNA42,47. In addition, acquired 
resistance of DNA to enzymatic degradation is another reason for cytosolic 
accumulation of nDNA. For instance, oxidative stress can cause oxidation of 
guanine bases to 8-hydroxydeoxyguanine (8-OHdG), which renders DNA 





Although 1) cytosolic accumulation of nDNA leads to inflammation, which plays 
a central role in AMD and 2) AMD has multiple risk factors and pathological processes, 
such as increased DNA damage (e.g., due to oxidative stress)49 and impaired 
autophagy50,51, that could potentially lead to cytosolic accumulation of nDNA, the role of 
this accumulation in AMD pathogenesis has not been studied. In the current study, we 
investigated the presence of cytosolic accumulation of nDNA fragments in AMD patients 






Hypothesis: cytosolic accumulation of nDNA fragments in RPE cells contributes to the 
development of AMD 
- Aim 1: Test the presence of cytosolic accumulation of nDNA fragments in macular 
RPE cells of AMD patients. 
- Aim 2: Identify the effects and molecular mechanisms triggered by cytosolic 
accumulation of nDNA fragments in RPE cells.  
2.1 Investigate the pathological effects triggered by cytosolic accumulation of 
nDNA fragments in RPE cells.  
2.2 Identify the DNA sensor that triggers RPE cells injury upon cytosolic 
accumulation of nDNA fragments. 
2.3 Investigate the signaling pathways that mediate the effects triggered by 
cytosolic accumulation of nDNA in RPE cells. 
2.4 Explore the paracrine mechanism of RPE cells with cytosolic accumulation of 
nDNA fragments.  
- Aim 3: Evaluate in vivo the retinopathy induced by conditional deletion of Dnase2a and 
cytosolic accumulation of nDNA  
3.1 Evaluate the retinal morphology and ultrastructure of mice with conditional 
deletion of Dnase2a. 
3.2 Evaluate the retinal function of mice with conditional deletion of Dnase2a. 
3.3 Test if deletion of Dnase2a in vivo results in retinal pathological effects 




CHAPTER TWO. METHODS 
  
Cell lines and reagents  
ARPE-19 cells (CRL-2302), THP-1 cells (TIB-202), and RPMI-1640 medium 
(30-2001) were purchased from the American Type Culture Collection (ATCC) 
(Manassas, VA). Dulbecco's Modified Eagle Medium/ Nutrient Mixture F-12 (DMEM/F-
12) (11330-057), heat-inactivated fetal bovine serum (HI-FBS) (10438-026) and 
Penicillin-Streptomycin (15140122), MEM non-essential amino acids solution 
(11140050), and L-Glutamine (25030081) were purchased from Life Technologies 
(Grand Island, NY). Recombinant human IL-1α (200-LA-010) was obtained from R&D 
Systems (Minneapolis, MN), and rapamycin (BML-A275-0005) from Enzo Life Sciences 
(Farmingdale, NY). N1 Medium Supplement (N6530), taurine (T0625), hydrocortisone 
(H4001), Triiodo-L-Thyronine (T3) (T5516), and Minimum Essential Medium Eagle 
(M4526) were purchased from (Sigma-Aldrich, St. Louis, MO). Anti-DNase IIa (ab8119) 
and p16 antibodies (ab108349) were obtained from Abcam (Cambridge, MA). Anti-IL-8 
antibody (MAB208) and Apolipoprotein J (MAB2937) antibodies were purchased from 
R&D Systems. Anti-β-Actin antibody (4970), anti-IL-6 (12153), anti-Phospho-Rb 
(Ser807/811) (9308), STING (13647), phospho-S6 ribosomal protein (Ser240/244) 
(5364), S6 ribosomal protein (2317), and HRP-linked secondary antibodies (7074, 7076) 
were obtained from Cell Signaling Technology (Danvers, MA). Anti-H2A.X Phospho 
(Ser139) (#613402) was obtained from Biolegend (San Diego, CA). ELISA kits for 




from R&D Systems (Minneapolis, MN). dsDNA antibody (sc-58749), STING shRNA, 
AIM2 shRNA (sc-88166-V), and control shRNA (sc-108080) lentiviral particles were 
purchased from Sant Cruz (Dallas, TX).  
 
Cell culture  
Primary RPE cells were cultured in Minimum Essential Medium Eagle medium 
supplemented with 10-15% heat-inactivated FBS in the first few days after isolation and 
reduced to 5% later on, 100 U/mL penicillin, and 100 μg/mL streptomycin, 2mM L-
Glutamine, 1X MEM non-essential amino acids solution, 125 mg of Taurine per 500 mL 
medium, 10 mg of Hydrocortisone per 500 mL medium, and 0.0065 mg of Triiodo-
thyronin per 500 mL medium, as previously described6.  
ARPE-19 cells were cultured in DMEM/F-12 medium supplemented with 10% 
heat-inactivated FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. THP-1 cells 
were maintained in RPMI-1640 medium supplemented with 10% HI-FBS, 100 U/mL 
penicillin, 100 μg/mL streptomycin, and 50 μM 2-mercaptoethanol. All cells were grown 
in humidified 5% CO2 at 37 °C and passaged when 90% confluent. 
 
Isolation of RPE Cells from Human Donor Eyes  
Human donor eyes, including AMD patients (66–91 years), age-matched controls 
(70 –90 years), and young individuals were obtained from the National Disease Research 
Interchange NDRI (Philadelphia, PA), the Minnesota Lions Eye Bank (Saint Paul, MN), 




provisions of the Declaration of Helsinki for research that involves human tissues. The 
average time between donor demise and procurement of eyes and receipt was 
approximately 4 hours (4 ± 1.1) and 35 hours (34 ± 5.3), respectively. Eyes were shipped 
in a moist chamber on wet ice.  
Globes were dissected under sterile conditions. Anterior segment, vitreous, and 
neural retina were carefully removed without damaging the underlying RPE cells. To 
remove any debris, the eyecup was rinsed gently with PBS supplemented with 5% FBS. 
Fundus photographs (with and without neural retina) were taken under a dissecting 
microscope equipped with a digital camera with a ruby sphere 1 mm in diameter on the 
center of the disc in AMD eyes for calibration. Fundus and posterior cup images were 
examined to detect any RPE abnormalities. An 8-mm sterile trephine was used to remove 
a disc of the RPE cell layer, Bruch’s membrane, and choroid from the macular and 
peripheral area. RPE cells were loosened by gentle scraping and collagenase digestion 
(20 minutes at 37°C). Cells were then collected and cultured in the primary RPE medium 
described in the previous section. Purity of the cultured cells was confirmed using RPE-
65 antibody staining, which showed 97% RPE cells.  
 
Western blot  
For checking the levels of secreted IL-6 and IL-8, ARPE-19 or primary human 
RPE (phRPE) cells with the indicated genotypes in the experiments were seeded in 12-
well plates and equal volumes of cell culture medium per well were used throughout the 




medium and then primed with IL-1α (at a concentration of 5 ng/ml) in serum-free 
medium for 12 hours (for experiments involving treatment with conditioned medium 
(CM), the cells were rinsed from the CM and primed with IL-1α in serum-free medium 
for 12 hours). Then, the culture medium was collected and centrifuged at 13.3 g for 15 
minutes at 4 °C. Also, equal volume of NP40 cell lysis buffer was added to each well and 
cell lysates were collected to detect β-actin to confirm equal protein loading. Equal 
volumes of culture medium (for IL-6, IL-8) or extracted protein (for β-actin) were used 
for western blot.  
For experiments to detect the levels of other proteins (e.g., p-RB, P16, Apo-J, 
STING, phospho-S6, and S6) in cell lysates, total protein concentration was determined 
by DC Protein Assay (Bio-Rad, Philadelphia, PA, US).  
Equal amounts of total protein (for cell lysates) or equal volume of culture 
medium were loaded on a NUPAGE 4-12% Bis-Tris polyacrylamide gel (Life 
Technologies, Grand Island, NJ) and subjected to electrophoresis. For detecting Dnase 
IIa, 12% Bis-Tris polyacrylamide gel was used. The proteins were transferred to a PVDF 
membrane (Millipore, Billerica, MA) and the membrane was subsequently blocked with 
5% wt/vol non-fat milk (9999, Cell signaling technology, Danvers, MA) in Tris-buffered 
saline, 0.1% Tween 20 (TBST) and incubated with primary antibodies against Dnase2a, 
p16, IL-8, apolipoprotein J at 1:1000. The membrane was blocked with 5% wt/vol bovine 
serum albumin (BP1600, Fisher Scientific, Rockford, IL) in TBST and incubated with the 
primary antibodies against β-Actin, IL-6, phospho-Rb, STING, phospho-S6 ribosomal 




primary antibodies overnight at 4 °C with gentle shaking. The membrane was then 
washed and incubated with HRP-conjugated secondary antibodies at room temperature 
for 60 minutes. The membrane was developed with enhanced chemiluminescence 
(RPN2232, ECL Prime western blotting detection reagents, GE Healthcare Life Sciences, 
Piscataway, NJ). The intensity of protein bands was measured using the software Image 
Lab 4.1 (Bio-Rad, Hercules, CA).  
 
Enzyme-linked Immunosorbent Assay (ELISA) 
IL-1β, IP-10, and VEGF secretion from Dnase2a KO ARPE-19 and hRPE was 
measured by analysis of culture medium of the cells using an ELISA kit ((DLB50), IP-10 
(DIP100), and VEGF (DVE00) from R&D Systems (Minneapolis, MN) according to the 
manufacturer’s instructions. The culture media were collected as mentioned in the 
previous section without priming the cells with IL-1α to measure VEGF levels.  
 
Production of CRISPR/Cas 9 Lentiviral Vector  
The knockdown of Dnase2a in ARPE19 and primary RPE cells was performed by 
CRISPR/Cas9 (clustered regularly interspaced short palindrome repeats) guided genome 
editing, following a workflow that is based on previous publications52-54. Lentiviral 
particles were used as vectors to integrate an expression cassette into the genome of the 
cells. This cassette codes for two single guide RNAs, the nuclease hSpCas9, and a 




CACCGACCCTTCGTGTGCCCACGCA- ́3 and 5 ́- 
AAACTGCGTGGGCACACGAAGGGTC - ́3 
Lentiviruses were created in HEK293T cells by transfection of three plasmids as 
described in [33,34]. Oligos for generation of sgRNA expression plasmids were annealed 
and cloned into the pHKO_23 vector.   
For the production of lentivirus, 80% confluent HEK293T cells in were co-
transfected with packaging plasmids vsv-g (addgene #14888) and PAX2 (addgene 
#35002) in OptiMEM (Life Technologies) and transfer plasmid , using 50μl Tran-IT- 
LT1 (Mirus Bio, #MIR2304). The medium was changed 12–14 h post-transfection to 
DMEM (Life Technologies) supplemented with 10% fetal bovine serum. After 48-60 
hours, lentivirus containing supernatants were harvested by centrifugation at 4°C and 
2000g for 15 minutes and purified by 0.45μm filtering. As control, a lentivirus produced 
from the same plasmid vector, but code for a scramble gRNA, was prepared using the 
same method.  
 
Viral transduction  
For transduction of CRISPR/ Cas9 lentivirus, cells were grown in 6-well plate and 
transduced with 1 ml of lentivirus containing supernatant supplemented with 2 μg/ml 
polybrene. After one day, 2 μg/ml puromycin was added to the media to select transduced 
cells and limiting dilution in 96 well plate was performed to select clones of Dnase2a and 
control ARPE-19 cells. For primary RPE cells, only puromycin selection was done 





Immunofluorescence for RPE cells 
Cells were seeded in a 8-well chamber slide (Cat#PEZGS0896, EMD Millipore, 
Billerica, MA) and cultured for 24-48 hours. The cells were then washed with DPBS 
(Cat# BE17-515Q, Lonza, Walkersville, MD, US) three times, after which 4% 
paraformaldehyde (Cat# 28906, Thermo Fisher Scientific, Rockford, IL, US) was used to 
fix the cells for five minutes. Then, the cells were washed with DPBS 3 times (5 minutes 
for each wash). Later on, cells were incubated with γ-H2AX or dsDNA antibody (1:100) 
at 4 °C overnight. IgG isotype was used as a negative control. Alexa Fluor 594-
conjugated antibodies (1:300; Life Technologies) were used as secondary antibodies. 
After rinse with DPBS, cells were mounted under a coverslip with Vectashield mounting 
medium (Cat# H-1000, Vector Laboratories, Burlingame, CA, US). The cell slide was 
observed and imaged using Leica TCS SP5 laser-scanning confocal microscope (Leica, 
Wetzlar, Germany). The Leica Application Suite (Version 2.6.0) so ware was used to 
collect the images. The final images were assembled with Image J (Version 2.0.0).  
 
Immunofluorescence for retina sections  
Mouse eyes snap frozen in O.C.T compound were cut into 10 μm sections. The 
frozen sections were postfixed with 4% paraformaldehyde for 15 min, blocked with 5% 
goat serum in phosphate-buffered saline (PBS). They were then incubated with the 
primary antibody at 4 °C overnight. A nonimmune serum was used as a negative control. 




secondary antibodies. Immunofluorescence images were acquired with a Leica SP2 
confocal microscope. 
 
Senescence β-Galactosidase Staining 
Cells growing in glass chamber was rinsed with PBS twice and then fixed in 4% 
PFA for 10 minutes following by 3 washes (10 minutes/each time) by PBS. The fixed 
cells were incubated in pre-warm (37°C) SA-β-gal staining solution (20% citric 
acid/sodium phosphate buffer pH=6.0; 1mg/ml 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside; 5mM postassium ferrocyanide; 5mM postassium ferricyanide; 
150mM sodium chloride; 2mM magnesium chloride) for 16 hours in dark. Then, samples 
will be observed under light microscope. 
 
RNA Extraction, RT-PCR and Quantitative Real-Time PCR 
The posterior eyecups of mice containing RPE/choroid and sclera were minced 
with scissors in lysis buffer (QIAGEN, Valencia, CA, USA). RNA extraction was 
performed with RNeasy plus micro kit (Qiagen, Valencia, CA, USA) according to 
manufacturer’s protocol. cDNA was synthesized with SuperScript III Reverse 
Transcriptase and Oligo(dT) Primer (Life Technologies). A real-time PCR assay was 
performed with Prism 7700 Sequence Detection System (Applied Biosystems, Foster 
City, CA, USA). The following primers for mouse Dnase2a were used (F 5’-
GCTCAGCTGGGGACTCTAC; R 3’-GGTCTGGCCGAAGGTTTGA). For relative 




method normalizing by an endogenous control (GAPDH; F 3’-
TGCACCACCAACTGCTTAGC; R’-GGCATGGACTGTGGTCATGAG).  For 
validation of RNA-seq results, Taqman primers (Thermo Fisher Scientific, Waltham, 
MA) were used.  
 
Transmission Electron Microscope (TEM)  
The eyes from wild-type and Dnase2a KO mice were enucleated and rinsed with 
PBS. Then they were immediately immersed in ½ Karnovsky fixative (2% formaldehyde 
and 2.5% glutaraldehyde in 100 mM cacodylate buffer, pH 7.4, containing 0.025% 
CaCl2) at 4°C. After 20 minutes fixation, eyes were dissected at the limbus and the 
anterior segment was separated from the posterior segment and the eyecups were placed 
back in the fixative. Within 24 hours of enucleation, the tissues were washed in 0.1 M 
cacodylate buffer and stored at 4°C. The tissues were post-fixed for 1.5 hours in 2% 
aqueous OsO4. The tissues were dehydrated in graded ethanols, transitioned in propylene 
oxide, infiltrated with propylene oxide and epon mixtures (tEpon, Tousimis) embedded in 
epon and cured for 24–48 hours at 60°C. One-micron sections were cut on a Leica 
Ultracut UCT and stained with 1% toluidine blue in 1% borate buffer. Areas selected 
from the 1 micron thick sections were further sectioned at 70–90 nm, stained with 







RNA-seq and all types of analysis 
RNA was isolated with RNeasy Plus Mini Kit (Qiagen, #74134). 1 ng RNA was 
used as template to generate full-length cDNA and sequencing libraries using the Smart-
seq2 protocol as previously described55. Libraries were sequenced on a NextSeq 500 
(Illumina) to an average depth of 12.4 million paired-end reads of length 38 bases each. 
Reads were mapped to the Gencode_v19 human transcriptome using Bowtie 2 
(Langmead and Salzberg, 2012) and expressions of all genes quantified using RSEM (Li 
and Dewey, 2011) to yield an expression matrix (genes x samples) of inferred gene 
counts. Differential expression was calculated with EBSeq version 1.10.056.  
 
Mice 
Both Dnase2a flox/- and Mx1-Cre mice were bred and genotyped to get Dnase2a 
flox/- Mx1-Cre  (Dnase2aKO/C Mx1-Cre) mice. Mx1-Cre littermates with matched age and 
sex were selected as controls. Both genotypes were injected intraperitoneally with 1.5 
μg/weight (g) of poly I:C three times every other day at 12–16 weeks of age to induce 
deletion of Dnase2a. Mice were housed in a specific pathogen-free facility at MEEI, and 
protocols were approved by MEEI IACUC in accordance with the institutional animal 
ethics guidelines.   
 
Fundus photography and Optical Coherence Tomography (OCT)   
Mice at 14 months age were anesthetized with intraperitoneal injection of 100 




0.5% tropicamide. Body temperature was maintained at 37C with a heating pad during 
the course of experiment. Fundus images were taken using the Micron III Retinal 
Imaging Microscope (Phoenix Research Laboratories, Pleasanton, CA) with the Micron 
camera lens using the StreamPix software (Phoenix Research Laboratories, Pleasanton, 
CA). OCT images were taken using Bioptigen Envisu SDOCT. 
 
Electroretinogram (ERG) 
Recordings were conducted in a dark room and mice were dark adapted for 16 
hours. Only Red LED headlamp was used during scotopic ERG recordings, fitted with 
red LED of the proper wavelength (λ~640nm) to prevent light adaptation of the mice. 
Animals were anesthetized with an intraperitoneal injection of ketamine (80 mg/kg) and 
xylazine (16 mg/kg). The pupils of mice were dilated with phenylephrine 5% and 
tropicamide 0.5% before recording. To maintain a normal body temperature at 37C, a 
temperature controller was used during anesthesia. To avoid dry eye and improve 
conduction, the recorded eyes were kept moist with hydromethylcellulose 2.5%. The 
OcuScience® HMsERG LAB System was adopted to record the signals. Signals were 
recorded using a silver-embedded thread electrode. Subcutaneous needles served as 






Intensity-response curves were recorded using 7 steps of increasing flash intensity 
(0.03, 0.1, 0.3, 1.0, 3.0, 10 and 30 mcd*s/m2). Responses to standard and high-intensity 





 Nuclear DNA fragments accumulate in the cytosol of the RPE of AMD 
patients 
 
To determine if there is cytosolic accumulation of nDNA fragments in macular 
RPE cells of AMD patients, we obtained from eye banks throughout the United States 
postmortem eye globes of Caucasian donors diagnosed with AMD (66-91 years old) and 
from age-matched healthy controls. Eye tissue sections were stained with an antibody 
against the phosphorylated form of histone H2AX (γH2AX), which is a marker of 
cytoplasmic chromatin fragments and damaged double-stranded nDNA (ds-nDNA)42,46,57. 
Interestingly, we found not only that RPE cells with accumulation of ds-nDNA are more 
prevalent in the macula of AMD patient donor eyes when compared to that in the macula 
of healthy age-matched controls (30% vs. 6%), but also that it is more prevalent when 
compared to that in the peripheral region of the AMD donor eyes (30% vs. 5%) (Fig 10 
A-D). Consistent with this, RPE cells with positive γH2AX were more abundant when 
near or abutting a drusen (Fig. 10 A), indicating that the accumulation of nDNA 
fragments in RPE cells correlates with the classical AMD pathology of drusen.  
Because immunohistochemistry does not allow for subcellular resolution, primary 
macular RPE cells from postmortem donor eyes were isolated, cultured and stained with 
an antibody against dsDNA to determine if there are indeed dsDNA fragments in the 
cytosol. The reason for choosing the dsDNA antibody is that histone proteins may be 




underrepresent the extent of cytosolic nDNA fragments. Analysis of the 
immunofluorescence staining corroborated that there is indeed a higher percentage of 
RPE cells with cytosolic accumulation of dsDNA fragments in the macula of AMD 
patients when compared to the periphery of the AMD affected eye or to an age-matched 
healthy control macula (60% vs. 22% and 17%, respectively; Fig. 10 E, F). 
To confirm that the cytosolic dsDNA fragments were indeed of nuclear and not 
mitochondrial origin, we co-stained RPE cells with DAPI and γH2AX antibody, which 
showed that γH2AX co-localized with most dsDNA fragments in large cytosolic 
aggregates proximal to the nucleus (Fig. 10 G-I). Taken together, our results clearly 































Figure. 10. Cytosolic accumulation of nDNA fragments in AMD patient macular 
RPE cells.  
(A-C) Representative images of immunohistochemistry staining for γH2AX in eye tissue 
sections from the indicated donors (scale bar = 50μm). In A, asterisk depicts drusen and 
arrows depict examples of RPE cells with positive γH2AX staining (red, visualized by 3-
Amino-9-ethylcarbazole). (D) Quantification of the percentage of RPE cells with positive 
γH2AX staining. Data are means ± SEM. (E) A representative image of 
immunofluorescence staining for cytosolic dsDNA (white arrow) in a macular RPE cell 
from an AMD patient donor eye (scale bar = 10μm). (F) Quantification of the percentage 
of RPE cells with positive dsDNA staining. (G-I) A representative image of 
immunofluorescence co-staining for cytosolic DAPI (blue, G) and γH2AX (red, H) in a 
macular RPE cell from an AMD patient donor eye. I represents a merged image (pink 
indicates co-localization). *P < 0.05, **P < 0.01, ***P < 0.001 from two-tailed Student’s 





Knockout of Dnase2a causes cytosolic accumulation of nDNA in RPE cells 
	
In order to study the downstream effects and molecular mechanisms of cytosolic 
accumulation of nDNA fragments in RPE cells, we established an RPE cell model with 
endogenous accumulation of nDNA in the cytosol.  
Dnase2a is an essential lysosomal endonuclease that is responsible for 
degradation of DNA fragments42,47. Knockout of Dnase2a has been reported to lead to 
accumulation of nDNA in both phagocytic and non-phagocytic cells42. Therefore, we 
knocked out Dnase2a in the human RPE cell line ARPE-19 and in primary human RPE 
(phRPE) cells isolated from healthy postmortem donors using CRISPR/Cas9 technology 
(Fig. 11 A), as mentioned in the methods section. The knockout of Dnase2a was 
confirmed by immunoblot analysis (Fig. 11 B, C). Loss of Dnase2a in ARPE-19 and 
phRPE cells led to cytosolic accumulation of nDNA fragments as evident by positive 
immunostaining of clones of DNase2a KO ARPE-19 cells and Dnase2a KO phRPE cells 
using dsDNA and γH2AX antibodies (Fig. 11 D).  
This indicates that both of our cell line models successfully recapitulates the 
pathology found in AMD patient macular RPE cells and can be used to study the 
consequences of cytosolic accumulation of nDNA fragments in RPE cells. 
To study these consequences, we performed a RNA-sequencing analysis on pure 
clones of Dnase2a KO ARPE-19 followed by a gene ontology analysis of the 
transcriptome alterations. The gene ontology analysis revealed aberrant regulation of 




of AMD, such as cell senescence, pro-inflammatory cytokine processes, and angiogenesis 

















































Figure 11. Knockout of Dnase2a in RPE cells using the CRISPR/Cas9 technology 
leads to cytosolic accumulation of nDNA fragments and aberrant regulation of 
multiple biological processes.  
(A) A Pair of single-guided RNA (sgRNA, blue) was designed to contain 20 nucleotides 
protospacer element that is complementary to the genomic DNA target sequence (red) in 
exon 4 of Dnase2a. Proto-spacer adjacent motif (PAM) sequence is marked in brown. 
Dnase2a immunoblotting of WT, scramble sg-RNA (Sc-sgRNA)-, and Dnase2a sgRNA-
transduced ARPE-19 cells (4 different clones) (B) and of Sc-sgRNA- and Dnase2a 
sgRNA-transduced primary human RPE (phRPE) cells (C). (D) Representative images of 
immunofluorescence staining for dsDNA and γH2AX in clones of Dnase2a knockout 
(KO) and Sc-sgRNA-transduced ARPE-19 cells as well as in Dnase2a KO and Sc-
sgRNA-transduced phRPE cells. (E) GO analysis from RNA-seq of Dnase2a KO ARPE-





Cytosolic accumulation of nDNA fragments promotes RPE cell senescence  
	
Numerous stresses can trigger cellular senescence, including DNA and chromatin 
perturbations58-61. Damage- or stress- induced senescence has been implicated in 
biological aging and numerous pathological conditions, including neurodegenerative 
diseases58-60,62-65. Importantly, RPE cells can undergo senescence in vitro 
66-70 and senescent RPE cells have been detected, using SA-β-gal staining, in the 
eyes of old, but not young, primates71. Furthermore, it was recently hypothesized that 
RPE senescence can be a key contributor to the pathogenesis of AMD because it accounts 
for the risk factors, signs, and successful treatment modalities of the disease70.  
Consistent with the cell senescence findings by gene ontology (Fig. 2 E), we 
observed that ARPE-19 cells with deletion of Dnase2a had a slower growth rate 
compared to WT and scramble CRISPR/ Cas9-transduced control cells (Fig. 12 A). In 
addition, ARPE-19 with deletion of Dnase2a displayed higher levels of SA-β-Gal 
staining (Fig. 12 B, C), higher expression levels of p16 protein, and hypophosphorylation 
of the retinoblastoma tumor suppressor protein (pRb), all of which are markers of cellular 
senescence58-61,72,73, compared to control (Fig. 12 D). Furthermore, these cells showed 
higher expression levels of clusterin/apolipoprotein J (APO-J) compared to control cells 
(Fig. 12 D). APO-J is a senescence-associated protein and one of the major proteins in 
drusen69,74,75.  
Finally, phRPE cells lacking Dnase2a also showed higher levels of SA-β-Gal 




our results in ARPE-19 and indicating that they are not an artifact of the ARPE-19 cell 
line but rather a consequence of cytosolic accumulation of nDNA in RPE cells. 
In total, these results indicate that cytosolic accumulation of nDNA fragments 











Figure 12. Cytosolic accumulation of nDNA fragments in Dnase2a KO RPE cells 
promotes cells senescence.  
(A) Growth curve of ARPE-19 cells with the indicated genotypes (WT-wild type, Sc-
sgRNA control, and 2 different cell clones with Dnase2a KO). (B) Representative images 
of SA-β-gal staining at different passages of ARPE-19 clones with or without Dnase2a 
deletion (Dnase2a KO or Sc-sgRNA-transduced ARPE-19 clones). (C) Quantification of 
the percentage of cells positive for SA-β-gal staining in (B). (D) Immunoblot of phospho-
RB, p16, APO-J, and β-actin (loading control) in cell lysate of 2 clones of ARPE-19 with 
Dnase2a deletion and control (Sc-sgRNA-transduced ARPE-19 clone). (E) A 
representative image of SA-β-gal staining of phRPE cells with Dnase2a deletion and 
control (Sc-sgRNA-transduced cells). (F) Quantification of the percentage of cells 
positive for SA-β-gal staining in (E). Experiments were repeated at least twice. Data are 





Cytosolic accumulation of nDNA fragments induces pro-inflammatory cytokines 
secretion in RPE cells 
	
As previously mentioned, cytosolic accumulation of nDNA induces inflammation. 
In addition, senescent cells can secret inflammatory cytokines as part of their senescence-
associated secretory phenotype (SASP), a phenotype that characterize senescent cells58-61.  
Our gene ontology findings showed aberrant regulation of pro-inflammatory 
cytokines processes in ARPE-19 cells with deletion of Dnase2a. To confirm the effect of 
cytosolic accumulation of nDNA fragments in RPE cells on some of the pro-
inflammatory cytokines that are linked to AMD, the levels of IL-6, IL-8, IL-1 β, 
interferon gamma-induced protein 10 (IP-10) were measured in the culture medium of 
two different clones of Dnase2a KO ARPE-19. The levels of IL-6 and IL-8 have been 
linked with the development and progression of AMD9,18,24-27. In addition, IL-1 β is 
increased in the vitreous and plasma of patients with AMD30 and IP-10, chemoattractant 
to Th1 cells, has been shown to serve as a possible biomarker for aging and AMD76,77.  
The data revealed higher levels of IL-6 and IL-8, as measured by immunoblot 
analysis (Fig. 13 A), IL-1 β (Fig. 13 B), and IP-10 (Fig. 13 C), as measured by ELISA, 
in the culture medium of Dnase2a KO ARPE-19 cells compared to control. 
Similar to the results with cell senescence, these findings were also confirmed in 
hRPE cells with Dnase2a loss (Fig. 13 D-F).  
Collectively, this indicates that cytosolic accumulation of nDNA fragments 




in aged RPE cells can result in an inflammatory microenvironment that aids in the 
































Figure 13. Cytosolic accumulation of nDNA fragments in Dnase2a KO RPE cells 
triggers pro-inflammation.  
(A) Immunoblot of IL-6 and IL-8 in equal volumes of culture media from two ARPE-19 
clones with Dnase2a deletion and control (Sc-sgRNA-transduced ARPE-19 clone). β-
actin was detected in each cell lysate to confirm equal number of cultured cells. Secretion 
of IL-1 β (B) and IP-10 (C) from ARPE-19 clones (average of 2 clones) with Dnase2a 
deletion and control (Sc-sgRNA-transduced ARPE-19 clone) as determined by ELISA of 
equal volumes of culture media. (D) Immunoblot of IL-6 and IL-8 in equal volumes of 
culture media from phRPE cells with Dnase2a deletion and control (Sc-sgRNA-
transduced cells). β-actin was detected in each cell lysate to confirm equal number of 
cultured cells. Secretion of IL-1 β (E) and IP-10 (F) from phRPE cells with Dnase2a 
deletion and control (Sc-sgRNA-transduced cells) as determined by ELISA of equal 
volumes of culture media. Experiments were repeated at least twice. Data are means ± 





Cytosolic accumulation of nDNA fragments induces VEGF secretion in RPE cells 
	
Angiogenesis is a key pathological process in the progression of dry AMD to 
neovascular “wet” AMD9,10. Our RNA-sequencing data showed an aberrant regulation of 
angiogenesis-related genes in ARPE-19 cells with Dnase2a loss (Fig. 2 E).  
Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen 
and vascular permeability factor that plays a pivotal role in the development of 
pathogenesis of choroidal neovascularization (CNV) in wet AMD10,78. In addition, 
senescent cells can secret increased levels of VEGF as part of SASP58 and inflammatory 
cytokines can also induce the secretion of VEGF in RPE cells. Therefore, we measured 
the levels of secreted VEGF in culture medium of ARPE-19 and phRPE cells with 
Dnase2a loss. 
Consistent with the RNA-sequencing analysis, our results showed that the levels 
of VEGF, as measured by ELISA, were higher in the culture medium of Dnase2a KO 
ARPE-19 and phRPE cells compared to control (Fig. 14 A, B). 
This indicates that cytosolic accumulation of nDNA fragments in RPE cells can 



































Figure 14. Cytosolic accumulation of nDNA fragments in Dnase2a KO RPE cells 
induces VEGF secretion.  
Secretion of VEGF from ARPE-19 clones (average of 2 clones) with Dnase2a deletion 
and control (Sc-sgRNA-transduced ARPE-19 clone) (A) and from phRPE cells with 
Dnase2a deletion and control (Sc-sgRNA-transduced cells) (B) as determined by ELISA 
of equal volumes of culture media. Experiments were repeated at least twice. Data are 





STING is an essential mediator for the phenotypes resulting from cytosolic 
accumulation of nDNA in RPE cells 
	
Our data show that cytosolic accumulation of nDNA fragments in RPE cells 
elicits a cascade of pathological events that are consistent with the pathology seen in 
human RPE cells of AMD patients. In order to develop therapeutic treatments to prevent 
or delay these events it is important to understand how these events are triggered. 
Normally, self-DNA in the cytosol is sensed by multiple DNA receptors that transmit the 
signal to downstream pathways and induce inflammation and cellular injury79-82. Most of 
these receptors generally signal to the stimulator of interferon genes (STING), a 
transmembrane protein that is located in the membrane of the endoplasmic reticulum and 
can itself sense DNA as well83,84. Fewer DNA sensors are STING-independent. 
To investigate which DNA sensor mediates the effects of cytosolic accumulation 
of nDNA in RPE cells, we screened some of the most known published DNA sensors. 
Absent in melanoma 2 (AIM2) is one of the most important cytoplasmic STING-
independent DNA sensors that has nonetheless been shown to crosstalk to STING79,80,85,86. 
AIM2 is expressed in brain cells and is upregulated in a murine model of chronic 
neurodegenration87. Our results revealed that loss of AIM2 in Dnase2a KO ARPE-19 
clones using shRNA led to reduction in the levels of secreted IL-6 and IL-8 (Fig. 15 A) 
with small, but statistically significant, reduction in secretion of VEGF (Fig. 15 B). 
However, it did not have any effect on the standard marker of senescence, SA-β-Gal 




cGAMP synthase (cGAS) is another important cytoplasmic DNA sensor79,80. It is 
the upstream of STING (i.e., STING-dependent) and has been recently reported to 
mediate cytosolic DNA-mediated cellular senescence and secretion of multiple 
inflammatory cytokines88. Interestingly, loss of cGAS in Dnase2a KO ARPE-19 cells 
using siRNA did not reduce the levels of IL-6 or IL-8 secretion (Fig. 15 E). Surprisingly, 
knocking down DNA-dependent activator of IRFs (DAI), another important cytoplasmic 
STING-dependent DNA sensor79,80, in Dnase2a KO ARPE-19 led to increase in the 
secretion of IL-6 and IL-8 (Fig. 15 F).  
This indicates that more than one DNA sensor are probably responsible for 
transmitting the signal of cytosolic nDNA in RPE cells and that inhibiting one of them 
only is not sufficient to prevent the cellular dysfunction resulting from this accumulation. 
Rather, it can even lead to activation of other DNA sensors with subsequent increase in 



















Figure 15. The effect of deleting AIM2, cGAS, and DAI on the consequences of 
cytosolic accumulation of nDNA in Dnase2a KO RPE cells. 
(A) Immunoblot of IL-6 and IL-8 in equal volumes of culture media from ARPE-19 
clones with Dnase2a deletion and control (i.e., Sc-sgRNA-transduced ARPE-19 clone) 
transduced with either control shRNA (shCNTL) or AIM2 shRNA (shAIM2) lentiviral 
vectors. β-actin was detected in each cell lysate to confirm equal number of cultured 
cells. (B) Secretion of VEGF from ARPE-19 clones with Dnase2a deletion and control 
(i.e., Sc-sgRNA-transduced ARPE-19 clone) transduced with the indicated vectors as in 
(A), as determined by ELISA of equal volumes of culture media. (C) Representative 
images of SA-β-gal staining in Dnase2a KO ARPE-19 clone transduced with the 
indicated vectors as in (A). (D) Quantification of the percentage of cells positive for SA-
β-gal staining in (C). Immunoblot of IL-6 and IL-8 in equal volumes of culture media 
from ARPE-19 clones with Dnase2a deletion and control (i.e., Sc-sgRNA-transduced 
ARPE-19 clone) transfected for 72 hours with either control siRNA (siCNTL), cGAS 
siRNA (sicGAS) (E), or DAI siRNA (siDAI) (F). Experiments were repeated at least 
twice. β-actin was detected in each cell lysate to confirm equal number of cultured cells. 
Data are means ± SEM. ns: not significant, *P < 0.05 from two-tailed Student’s t test to 





This led us to investigate the role of STING, which forms a common downstream 
node to most DNA-sensing pathways making it a strong candidate as a therapeutic target 
to modulate the innate immune defenses of the cells79,83,84. Interestingly, the results 
showed that STING was not only upregulated upon loss of Dnase2a in ARPE-19 cells 
(Fig. 16 A), but that concomitant loss of STING, using shRNA (Fig. 16 B), and Dnase2a 
in ARPE-19 cells prevented cell senescence, as measured by SA-β-Gal staining (Fig. 16 
D, E). The growth rate of Dnase2a/STING KO ARPE-19 cells was also similar to control 
cells (Fig. 16 C). In addition, this concomitant loss of STING and DNase2a led to 
reduction in the levels of secreted IL-6, IL-8, and IL-1 β (Fig. 16 F, G). Furthermore, it 
reduced the levels of secreted VEGF (Fig. 16 H).  
The data indicate that STING is an essential mediator of the effects that result 






















Figure. 16 STING is an essential mediator of the effects resulting from cytosolic 
accumulation of nDNA in RPE cells.  
(A) STING Immunoblot of Dnase2a KO and Sc-sgRNA-transduced ARPE-19. (B) 
STING immunoblot of  Dnase2a KO ARPE-19 transduced with either control shRNA 
(shCNTL) or STING shRNA (shSTING) lentiviral vectors. (C) Growth curve of WT 
ARPE-19 and Dnase2a KO ARPE-19 clone transduced at an early passage with the 
indicated vectors (shCTRL or shSTING). (D) Representative images of SA-β-gal staining 
in Dnase2a KO ARPE-19 clone transduced with the indicated vectors as in (C). (E) 
Quantification of the percentage of cells positive for SA-β-gal staining in (D). (F) 
Immunoblot of IL-6 and IL-8 in equal volumes of culture media from ARPE-19 clones 
with Dnase2a deletion and control (i.e., Sc-sgRNA-transduced ARPE-19 clone) 
transduced with the indicated vectors as in (C). β-actin was detected in each cell lysate to 
confirm equal number of cultured cells. Secretion of IL-1 β (G) and VEGF (H) from 
ARPE-19 clones with Dnase2a deletion and control (i.e., Sc-sgRNA-transduced ARPE-
19 clone) transduced with the indicated vectors as in (C), as determined by ELISA of 
equal volumes of culture media. Experiments were repeated at least twice. Data are 
means ± SEM. *P < 0.05, ***P < 0.0001 from two-tailed Student’s t test to compare each 





Inhibition of mTORC1 activity is able to alleviate the phenotypes resulting from 
cytosolic accumulation of nDNA in RPE cells 
	
A recent interesting study showed that S6K, an mTOR downstream effector and 
kinase, interacts with STING when mouse bone marrow–derived myeloid dendritic cells 
(BMDCs) are exposed to DNA viruses and this interaction is necessary for the induction 
of the transcription factor IRF389. Our RNA-sequencing data suggests that mTORC1 
activity is increased upon loss of Dnase2a in ARPE-19. This finding was corroborated by 
immunoblot analyses for the phosphorylated level of ribosomal protein S6 (p-S6), a 
direct target of S6K and a bona fide readout of mTORC1 activity, that was increased in 
ARPE-19 cells with Dnase2a loss compared to control (Fig. 17 A). mTOR pathway has 
been shown to be activated in many aging-related diseases and it is inhibited by 
rapamycin, an FDA-approved immunesuppressive drug90.  
Consistent with this aforementioned publication showing that the SK6-STING is 
required for activation STING downstream factors and our own data showing increased 
mTOCR1 activity upon loss of Dnase2a in ARPE-19 cells, we found that treatment of 
early passage ARPE-19 cells that lack Dnase2a with 1nM of rapamycin for 5-6 weeks 
prevented cellular senescence, as measured by SA-β-gal staining (Fig. 17 B, C). In 
addition, this treatment reduced the levels of secreted IL-6 and IL-8, as measured by 
immunoblot analysis of culture medium, and IL-1 β and VEGF, as determined by ELISA 




This suggests that rapamycin, an already FDA-approved drug, could potentially 
be used to inhibit the downstream effects induced by accumulation of nDNA fragments 
in the cytosol of RPE cells and thus to delay the progression of AMD. 
To investigate the possible interaction between mTOR pathway and STING in 
RPE cells upon cytosolic accumulation of endogenous nDNA fragments, we checked the 
levels of p-S6 in Dnase2a KO and Dnase2a/STING KO ARPE-19 cells. Immunoblot 
analysis showed that the levels of p-S6 were reduced in Dnase2a/STING KO compared 
to Dnase2a KO ARPE-19 (Fig. 17 G). This suggests the presence of a possible 
interaction between mTOR pathway and STING that mediates the effects of cytosolic 
























Figure 17. Inhibition of mTORC1 activity is able to alleviate the phenotypes 
resulting from cytosolic accumulation of nDNA in RPE cells.  
(A) Immunoblot of phospho-S6 (p-S6), total S6, and β-actin (loading control) in cell 
lysate of 2 clones of ARPE-19 with Dnase2a deletion and control (Sc-sgRNA-transduced 
ARPE-19 clone). (B) Representative images of SA-β-gal staining in Dnase2a KO ARPE-
19 clone treated with 1nM of rapamycin or vehicle for 5-6 weeks. (C) Quantification of 
the percentage of cells positive for SA-β-gal staining in (B). (D) Immunoblot of IL-6 and 
IL-8 in equal volumes of culture media from ARPE-19 clones with Dnase2a deletion and 
control (i.e., Sc-sgRNA-transduced ARPE-19 clone) treated with rapamycin as in (B). 
Secretion of IL-1 β (E) and VEGF (F) from ARPE-19 clones with Dnase2a deletion and 
control (i.e., Sc-sgRNA-transduced ARPE-19 clone) treated with rapamycin as in (B), as 
determined by ELISA of equal volumes of culture media. (G) Immunoblot of phospho-
S6, total S6, and β-actin (loading control) in cell lysates of Dnase2a knockout and Sc-
sgRNA-transduced ARPE-19 transduced with either control shRNA (shCNTL) or STING 
shRNA (shSTING) lentiviral vectors. Experiments were repeated at least twice. Data are 
means ± SEM. ***P < 0.0001, ****P < 0.0001 from two-tailed Student’s t test to 





Cytosolic accumulation of nDNA fragments in RPE cells has a detrimental 
paracrine effect  
	
Contribution of cellular senescence to disease does not only arise from the cellular 
dysfunction it causes, but also from its effects on the tissue microenvironment through 
SASP, a pathological condition where senescent cells secrete molecules that affect the 
well being of neighboring cells (autocrine, paracrine and systemic effects of cell 
senescence) 58,60,61.  
To test the ability of cytosolic accumulation of nDNA fragments in driving 
paracrine RPE cell senescence, we exposed WT ARPE-19 cells to conditioned medium 
(CM) from senescent ARPE-19 cells with loss of Dnase2a and control CM from scramble 
CRISPR/ Cas9-transduced ARPE-19 cells with no senescence.  
The results showed that CM from ARPE-19 cells with loss of Dnase2a effectively 
propagated senescence in a paracrine manner, as shown by the induction of SA-β-gal 
expression in about 30% of WT ARPE-19 (Fig. 18 A, B). This CM also induced the 
secretion of IL-6, IL-8 (Fig. 18 C), and VEGF (Fig. 18 D) in WT ARPE-19. 
Furthermore, the same CM resulted also in higher secretion of tumor necrosis factor α 
(TNFα) from the human macrophage cell line THP-1 compared to control CM (Fig. 18 
E).  
Taken together, the results show that cytosolic accumulation of nDNA fragments 
in RPE cells induces SASP and that this phenotype can affect neighboring RPE cells. The 
data thus suggests that even a small fraction of the aged RPE cells with cytosolic 




RPE cells and possibly in adjacent photoreceptor cells. This could explain the continuous 
expansion of areas of RPE atrophy in humans with Geographic Atrophy (GA), the late 
































Figure 18. Paracrine effects of RPE cells with cytosolic accumulation of nDNA.  
(A) Representative images of SA-β-gal in WT ARPE-19 cells treated for 3 weeks with 
conditioned medium (CM) of senescent Dnase2a KO ARPE-19 cells or Sc-sgRNA-
transduced ARPE-19 cells with no senescence. (B) Quantification of the percentage of 
cells positive for SA-β-gal staining in (A). (C) Immunoblot of IL-6 and IL-8 in equal 
volumes of culture media from WT ARPE-19 ells treated for three weeks with CM of 
two clones of senescent Dnase2a KO ARPE-19 cells or Sc-sgRNA-transduced ARPE-19 
cells with no senescence. β-actin was detected in each cell lysate to confirm equal 
number of cultured cells. (D) Secretion of VEGF from WT ARPE-19 cell treated as in 
(C), as determined by ELISA of equal volumes of culture media. (E) TNFα secretion, as 
determined by ELISA of equal volume of culture media, from THP-1 cells treated for 5 
days with CM of senescent Dnase2a KO ARPE-19 cells or Sc-sgRNA-transduced ARPE-
19 cells with no senescence and then activated with 10 μg/μl LPS and 5 mM ATP. 
Experiments were repeated at least twice. Data are means ± SEM. **P < 0.01, ***P < 





CHAPTER FOUR. IN VIVO STUDIES  
 
Cytosolic accumulation of nDNA in Dnase2a KO mice results in AMD-like 
retinopathy 
	
To generate a mouse model with endogenous nDNA fragment accumulation in 
the cytosol of RPE cells, we pursued the same strategy used for the ARPE-19 and phRPE 
cells. Dnase2a conditional mice were used. To avoid any confounding phenotypes due to 
deletion of Dnase2a during development, we used the Mx1-Cre mouse line, which is an 
inducible Cre-line with broad tissue expression in adult mice and has been used 
previously in the eye91. We generated mice with one knockout (KO) allele of Dnase2a 
and one conditional allele (C) in the presence of the Mx1- Cre (Dnase2aKO/C Mx1-Cre). 
Because Cre expression is under the control of the Mx1 promoter, its expression can be 
induced by intra-peritoneal injection of poly(I:C)32,42. Administration of poly(I:C) at 4 
months of age resulted in a 90% reduction in Dnase2a RNA levels in the RPE/Choroid 
layer when compared to control injected mice (Dnase2a+/+ Mx1-Cre) as evaluated by 
qRT-PCR at 8 months post injection (1 year of age) (Fig. 19 A). Interestingly, deletion of 
Dnase2a induced cytosolic accumulation of nDNA fragments mainly in the RPE layer 


















Figure 19. nDNA accumulates in the cytosol of the RPE of mice with conditional 
deletion of Dnase2a.  
(A) Quantitative RT-PCR (qRT-PCR) for Dnase2a using RNA isolated from the retinas 
of conditional Dnase2a KO and control mice 8 months post poly (I:C) injection (1 year of 
age). (B) A representative image of immunofluorescence co-staining for DAPI (blue) and 
γH2AX (green) (upper panel) as well as DAPI (blue) and dsDNA (green) (lower panel) 





Funduscopy analysis of these mice at 1 year of age showed significant increase in 
drusen-like deposits (Fig. 20 A), which were located either beneath or above the RPE as 
shown by Optical Coherence Tomography (OCT) imaging (Fig. 20 B) and Transmission 
Electron Microscopy (TEM) (Fig. 20 C). The RPE showed increased autofluorescence, 
which represents accumulation of lipofuscin (Fig. 20 D). OCT also detected a significant 
































Figure 20. Mice with conditional deletion of Dnase2a develop AMD-like retinopathy.  
(A) Representative fundus images of conditional Dnase2a KO and control mice showing 
drusen-like deposits in retinas of mice with Dnase2a deletion. (B) Representative OCT 
scans for the retinas of conditional Dnase2a KO and control mice. Images showing the 
presence of drusen-like deposits on top (yellow arrows) and beneath RPE (red arrow), 
and the penetration of light into the underlying choroid is increased in the center of 
drusen (red arrow head) in conditional Dnase2a KO mice. (C) Representative TEM 
images for the retinas of conditional Dnase2a KO and control mice. Drusenoid deposits 
are either on top (yellow asterisk, top panel) or beneath the RPE (yellow asterisk, low 
panel) in conditional Dnase2a KO mice. Scale bar = 5μm. (D) Representative 
autofluorescence images for retina sections of conditional Dnase2a KO and control mice. 
Images showing increased autofluorescence in the RPE of mice with Dnase2a deletion 
(white arrow). Scale bar = 50μm. n = 5 control and 5 Dnase2a KO mice. Analyses were 





























Figure 21. Retinal thickness is decreased in mice with conditional deletion of 
Dnase2a. 
Quantification of the thickness of retinal outer nuclear layer (ONL) and photoreceptor 
inner segments (IS) in conditional Dnase2a KO and control mice. The thickness was 
measured by OCT every 250 µm moving from the optic nerve head (ONH) to the 
periphery. n = 5 control and 5 Dnase2a KO mice. Data are means ± SEM. **P < 






In addition, TEM revealed basal laminar deposits, a thickening of the Bruch’s 
membrane, a reduction in the basal infoldings of the RPE plasma membrane, 
vacuolization in RPE cells, and the loss of photoreceptors and RPE cells (Fig. 22), all of 
which are pathological features of AMD, confirming the structural damage of the retinas 




































Figure 22. Mice with conditional deletion of Dnase2a develop retinal degeneration.  
Representative TEM images for the retinas of conditional Dnase2a KO and control mice. 
Top panel: Normal basal infoldings (left), Bruch’s membrane (middle, yellow dotline) 
and RPE cell structure (right). Bottom panel: Structural defects in basal infolding (left, 
yellow arrows), structural defects and thickening of Bruch’s membrane (middle, yellow 
dotline), and photoreceptor loss (yellow asterisk) and vacuolization inside RPE cells (red 





To assess the function of the retina in Dnase2a KO mice, we performed scotopic 
electroretinogram (ERG), as mentioned in the methods. Briefly, recordings were 
conducted in a dark room and mice were dark adapted 16 hours. A testing protocol with 
light stimuli of 3,000 and 10,000 cd*s/m2 showed that amplitudes of a wave, which is 
derived from the cones and rods of the outer photoreceptor layers92, and b wave92, which 
is derived from the inner retina, predominantly Muller and ON-bipolar cells, were 
decreased in response to each light stimulus in Dnase 2a KO mice compared to control 
mice (Figure 23 A). In addition, Intensity-response curves were recorded using 7 steps of 
increasing flash intensity (0.03, 0.1, 0.3, 1.0, 3.0, 10 and 30 mcd*s/m2). We found that 
the amplitude of the positive scotopic threshold response (pSTR) was significantly lower 
in Dnase2a KO compared to control mice under stimuli no less than 0.0003 cd*s/m2 
(Figure 23 B). Since pSTR is assumed to be produced by activity from the proximal 
retina, specifically amacrine and ganglion cells, in mice92, our results indicate that the 

















Figure 23. Mice with conditional deletion of Dnase2a develop retinal dysfunction.  
(A) Left: ERG plot for conditional Dnase2a KO and control mice in response to a light 
flash. The amplitude of a- and b-waves are measured in each flash intensity. Right: 
quantifications of the amplitude of a- and b-waves. (B) Left: intensity response curves of 
the 7 light stimulation intensities (0.03, 0.1, 0.3, 1.0, 3.0, 10 and 30 cd*s/m2). The 
amplitude of pSTR are measured in each flash intensity. Right: quantifications of the 
amplitude of pSTR. n = 5 control and 5 Dnase2a KO mice. Data are means ± SEM of the 
amplitudes (μV). ***P < 0.005 from two-tailed Student’s t test. Analyses were conducted 





Collectively, the data of our mouse model not only recapitulate the cytosolic 
accumulation of nDNA found in the RPE of AMD patients but also indicate that this 







To study the possible mechanisms that lead to AMD-like retinopathy in Dnase2a 
KO mice, we performed a RNA-sequencing analysis on retinas of Dnase2a KO and 
control mice followed by a gene ontology analysis of the transcriptome alterations. The 
differentially expressed genes and the gene ontology analysis revealed aberrant regulation 
of some biological processes involved in the pathogenesis of AMD. These were 
dominated mainly by inflammatory and immune responses followed by regulation of cell 




























































Figure 24. Knockout of Dnase2a leads to aberrant regulation of multiple biological 
processes in mice retinas. 
GO analysis from RNA-seq of Dnase2a KO mice retinas showing the most significant 





CHAPTER FIVE. DISCUSSION  
 
In our study, we found that nDNA fragments accumulate in the cytosol of macular 
RPE cells of AMD patients. Mimicking this pathology by deleting the lysosomal 
endonuclease Dnase2a, which is responsible for the degradation of DNA fragments, in 
RPE cells induced cell senescence and led to secretion of higher levels of pro-
inflammatory cytokines and VEGF compared to control. Additionally, similar to other 
senescent cells, we found that these senescent RPE cells secrete factors that act in a 
paracrine manner turning otherwise healthy RPE cells into senescent cells that start 
secreting VEGF as well as pro-inflammatory cytokines. We also identified STING, a 
main downstream node in DNA sensing pathways, as a crucial intermediary that is 
required for the induction of the phenotypes seen upon cytosolic nDNA accumulation. In 
addition, we showed that an interaction between mTORC1 and STING signaling exists in 
ARPE-19 cells and that the mTORC1 inhibitor rapamycin reduced the phenotypes 
resulting from cytosolic accumulation of nDNA fragments. Finally, we found that mice 
with Dnase2a deletion develop AMD-like retinopathy, such as drusen formation and 
Bruch’s membrane thickening, show retinal dysfunction, and have aberrant biological 
processes involved in AMD pathogenesis. To our knowledge, this is the first study that 
links cytosolic accumulation of nDNA fragments to AMD. 

















Cytosolic Accumulation of nDNA in the RPE cells of AMD patients. Why? 
 
While nuclear DNA is traditionally viewed as the carrier of the genetic 
information, recent reports clearly show that cytosolic nDNA can act as a ‘danger signal’ 
thereby activating the immune system to cope with aberrant cellular activities43,88,93-95. As 
mentioned in the introduction, this immune system activation has not only been linked to 
the induction of a pro-inflammatory response but also to many inflammatory and 
autoimmune diseases. Recently, nDNA and chromatin fragments have been shown to 
“leak out” the nuclei of cells during senescence46,93 and induce pro-inflammatory 
responses and senescence-associated secretory phenotype (SASP) through activating the 
innate immunity, such as cGAS-STING pathway88,93,95.  
Under steady-state conditions, nDNA replication debris and damaged nDNA are 
exported in a controlled manner from the nucleus to the cytosol for degradation in the 
lysosome42,43,81. The nuclear-to-autophagosome and the autophagosome-to-lysosome 
transport pathways are both crucial for proper disposal of nDNA fragments42. Therefore, 
cytosolic accumulation of nDNA can result from one or more of the following 
mechanisms, which were discussed in the introduction section: increased de novo 
production of nDNA fragments, disruption of the nuclear envelop integrity, defective 
autophagy machinery, or impairment in the DNA degradation machineries. The 




patients is not yet known, but it is reasonable to speculate that one or more of the 
following mechanisms contribute to this phenomenon in AMD patients: 
 
      1. Increased production of nDNA fragments, such as the increased production of 
damaged nDNA. DNA damage can result from three sources. First, spontaneous 
alterations during DNA reactions and metabolism can cause abasic sites and other 
modifications of the DNA bases96-98. Second, normal cell metabolism generates 
many endogenous factors that damage the DNA, such as reactive oxygen species 
(ROS) and lipid peroxidation products98,99. Third, exogenous physical (e.g., 
ionizing radiation and ultraviolet light from sunlight) and chemical (e.g, cigarette 
smoking) agents can cause a wide variety of DNA damage types96,98. Despite the 
high quality DNA repair system, there is accumulation of endogenous damaged 
DNA in the steady state of the cell. This accumulation increases with age because 
the capacity of DNA damage repair declines as the cells age100-103 and it is 
particularly prevalent in non-replicating (i.e., post-mitotic) or slowly replicating 
cells, such as brain, RPE, and muscle cells103. The RPE and other retinal cells 
have a state of elevated oxidative stress and reactive oxygen species (ROS). In 
addition, many other DNA damaging agents and factors that lead to accumulation 
of nDNA damage, including aging, smoking, sunlight exposure, and 
inflammation, are risk factors for AMD9,98,104. Importantly, polymorphism in the 
genes encoding some proteins that play important roles in the repair of oxidative 




pathogenesis of AMD105. Collectively, increased production of damaged nDNA 
fragments could be an important mechanism that leads to cytosolic accumulation 
of nDNA fragments.  
     2. Defective autophagy machinery. Autophagy is an essential catabolic pathway 
for degradation and recycling of cellular components in the lysosome. It plays a 
key role in cellular quality control, especially in post-mitotic or slowly replicating 
cells, because the total burden of damaged molecules and organelles can not be 
minimized by redistribution to daughter cells through cell division51. The main 
and most described form of autophagy is macroautophagy, in which the 
cytoplasmic material that needs to be degraded is engulfed in a double-membrane 
structure, which forms the autophagosome, that fuses with lysosomes for 
degradation of the engulfed material by acidic enzymes51. As previously 
mentioned, the nuclear-to-autophagosome and the autophagosome-to-lysosome 
transport pathways are both crucial for proper disposal of nDNA fragments42. 
Although the role of autophagy in AMD and other neurodegenerative diseases is 
complex and could differ depending on the stage of the disease, much evidence 
support the presence of dysfunctional autopahgy in the RPE cells of AMD 
patients50,51. Therefore, the defective autophagy machinery could be an important 
mechanism that leads to cytosolic accumulation of nDNA fragments in RPE cells 
of AMD patients.  
      3. Impairment in DNA degradation machineries. As previously mentioned, 




degrade DNA fragments that are transported to the lysosome by hydrolyzing the 
phosphodiester backbone of DNA molecules by a single-strand cleavage (nicking) 
mechanism47. It exhibits an acid pH optimum of approximately 5.047 and thus pH 
and sequestration within a normal lysosomal compartment are likely the main 
factors that regulate the activity of Dnase2a47. It has been reported that the activity 
of Dnase2a of chick brain decreases with age106, but similar studies are not 
available in the retina. As part of the dysfunctional autophagy, alterations in the 
lysosomes and lysosomal pH have been shown to be present in RPE cells of AMD 
patients51. Therefore, these alterations could greatly affect the activity of Dnas2a 
and contribute to the cytosolic accumulation of nDNA fragments in RPE cells of 
AMD patients. Further studies are needed to evaluate the activity of Dnase2a in 





Downstream effects triggered by cytosolic accumulation of nDNA in RPE cells.  
Significance for AMD pathogenesis  
 
Traditionally, cell senescence is defined as a permanent state of cell growth arrest 
that is unresponsive to growth factors58,59. This phenomenon was first observed in 
cultured human fibroblasts, which have a replicative limit (Hayflick limit) as a 
consequence of the gradual shortening of telomeres60,107-109. Telomere attrition induces a 
persistent DNA damage response, which initiates and maintains irreversible cellular 
growth arrest and senescence58. However, it was later shown that numerous stresses can 
trigger cellular senescence, including non-telomeric DNA damage, especially DSBs, 
oncogenic activation, chromatin perturbations, strong mitogenic signals, oxidative stress, 
UV radiation, and chemical damage or therapeutic drug toxicity58-61. While in vitro 
senescence is well studied and characterized, it has been technically challenging to study 
in vivo senescence, especially in non-proliferating tissues, which have been found to 
show some characteristic senescence markers, suggesting that the traditional definition 
may not apply to in vivo senescence.  
In addition to growth arrest, senescent cells have characteristic phenotypes that 
can be used as senescence markers. These include senescence­-associated β-
­galactosidase (SA-­β-gal) positive staining, which reflects an increased lysosomal 
biogenesis that commonly occurs in senescent cells and is widely used as the standard 
marker for in vitro and in vivo senescence58-60,72,73. Some of the other characteristics that 




morphology58, lack of DNA replication and proliferation markers59,60, increased ROS 
production and the resulting accumulation of ROS-mediated damage products58, changes 
in chromatin organization in some senescent cells known as senescence-associated 
heterochromatin foci formation (SAHF) and senescence-associated DNA ­damage foci 
(SDF), altered expression of numerous genes, including known cell cycle inhibitors or 
activators like p16, P21, P53, and pRB, resistance to cell death signals (known as 
apoptosis resistance), and acquisition of the senescence-associated secretory phenotype 
(SASP), which includes secreted soluble inflammatory (interleukins and chemokines) and 
growth factors, secreted proteases, and secreted insoluble proteins/extracellular matrix 
(ECM) components that participate in tissue remodeling58-61. 
Cell senescence plays a role in development (developmentally programmed 
senescence) and in adult physiology58,63-65 as a response to developmental cues, 
polyploidy, and cell-cell fusion58,63. For instance, multiple embryonic structures and 
organs in many species undergo programmed senescence, including the mesonephros, the 
endolymphatic sac, the brain, the eye, and the apical ectodermal ridge (AER)63. In 
addition, normal megakaryocytes, placental syncytiotrophoblasts, and decidual NK cells 
in adult organisms undergo physiologically programmed senescence as part of their 
natural maturation programs63.  
On the other hand, damage- or stress- induced senescence has been implicated in 
wound healing and tissue repair, biological aging, and numerous pathological conditions 
and its role can be beneficial or detrimental depending on the context and on the 




senescence to diseases does not only arise from the cellular dysfunction it causes, but also 
from causing impairment of tissue regeneration and from its effects on the tissue 
microenvironment through SASP (autocrine, paracrine and systemic effects of cell 
senescence)58,60-62.  
Senescence is a hallmark of aging and senescent cells accumulate in aged tissues 
of rodent, non-guan primates, and human65,72,110-113. Interestingly, removal of senescent 
cells in mice delays the aging process and age-associated disorders65,114,115. Some of the 
senescence-associated diseases are cancer, organ fibrosis (e.g., pulmonary, liver, renal, 
cardiac, and pancreatic fibrosis), vascular diseases (e.g., atherosclerosis, brain aneurysm, 
and aortic aneurysm), metabolic disorders (e.g., obesity and type 2 diabetes), muscle 
disorders (e.g., sarcopenia), bone and cartilage disorders (e.g., osteoarthritis), 
neurodegenerative diseases (e.g., Alzheimer’s disease and Parkinson’s disease), and 
ocular diseases (e.g., cataract and glaucoma) 63,65. Therefore, cell senescence has been 
studied as a therapeutic target to treat many chronic and age-related diseases63,65. 
Advanced age is the biggest risk factor for AMD9,11-14. Thus, it is surprising that 
cellular senescence has not been extensively studied in AMD, especially when 
considering that RPE cells can undergo senescence in vitro and senescent RPE cells have 
been detected in vivo, using SA­βgal staining, in the eyes of old, but not young, 
primates66-71. In addition, the senescence-prone mouse strain 8 (SAMP8) has been found 
to result in photoreceptor loss and increased p16 expression in the RPE116. Recently, RPE 
cells senescence has been hypothesized to be a key-contributing factor to the 




treatment modalities of the disease70. For instance, IL-6 and IL-8, which are essential 
components of SASP58,61, play an important role in the development and progression of 
AMD24-28. Similarly, VEGF, which plays a pivotal role in the pathogenesis of neovascular 
AMD, is also an essential component of SASP58. In addition to shedding light on RPE 
cells senescence as a contributing mechanism to AMD pathogenesis through autocrine 
and paracrine effects, our study clearly shows that cytosolic accumulation of nDNA 
fragments can cause cell senescence, a concept that, according to our knowledge, has not 
been well studied so far.  
As previously mentioned, inflammation and angiogenesis are two main 
mechanisms that contribute to the pathogenesis of AMD. Inflammation, specifically para-
inflammation, has been recognized widely as a central player in all stages of AMD. For 
instance, many cytokines, such as IL-6, IL-8, IL-1β, IL-12, and TNF-α, are strongly 
associated with AMD. In addition, the complement system plays an important role in 
AMD pathogenesis and alterations in genes encoding complement factors are strongly 
associated with AMD. On the other hand, VEGF-induced angiogenesis plays a key role 
in the progression of dry to wet AMD. Since SASP is an important feature of senescent 
cells, the observed increase in pro-inflammatory cytokines and VEGF in RPE cells with 
cytosolic accumulation of nDNA fragments could be part of the senescence phenotype 
that results from the presence of nuclear DNA in the cytosol. However, this could also be 
a direct result for sensing nuclear DNA in the cytosol by the innate immune system. In 
turn, this immune response and the resulting chronic inflammation can induce cell 




contributing factor to senescence and age-related diseases as well as VEGF 
secretion9,18,117. The ability of AIM2 deletion in Dnase2a KO RPE cells to partially reduce 
the levels secreted pro-inflammatory cytokines and VEGF without affecting the 
percentage of cells with positive SA-β-gal staining may suggest that the pro-
inflammation and VEGF phenotypes in these cells are, at least partially, independent 
from the senescence phenotype. Confirming whether inflammation is part of the 
senescence phenotype in RPE cells with cytosolic accumulation of nDNA or a separate 
process is a question that needs further investigation in future studies.  
Most studies centered on AMD focus on one risk factor or mechanism at the time, 
an approach that has not lend itself to success for this multifactorial aging condition. The 
presence of cytosolic accumulation of nDNA in RPE cells of AMD patients and its ability 
to induce multiple factors that are suggested or known to contribute to AMD, such as 
RPE cell senescence, pro-inflammation, and VEGF secretion, provide thus insights into a 
novel phenomenon that contributes to this multifactorial disease through multiple 





Cytosolic DNA sensors: any role in AMD? 
 
Cytosolic DNA sensors are innate immune receptors sensing DNA. Although 
originally studied in the context of sensing and responding to viral and bacterial nucleic 
acids, numerous studies have shown that these sensors also sense self-DNA and play a 
role in immune-mediated diseases79-82. More recently, the DNA sensing pathway cGAS-
STING was found to play a role in cell senescence as well, providing a link between the 
innate immune system and the process of cellular senescence and SASP88. The role of 
nucleic acid sensors in AMD has not been studied until very recently when Kerur et al. 
reported that Alu-RNA accumulation triggers cytosolic escape of mitochondrial DNA in 
RPE cells, which engages cGAS and drives non-canonical inflammasome activation in 
AMD118.  
Our results, however, showed that deletion of cGAS as well as the other DNA 
sensor DAI in RPE cells did not prevent the increased secretion of pro-inflammatory 
cytokines induced by cytosolic accumulation of nDNA, indicating the absence of a key 
role for these two sensors in sensing nDNA in RPE cells. However, deletion of AIM2 
partially prevented the pro-inflammatory cytokines as well as VEGF secretion, indicating 
the presence of a role for AIM2 in mediating some of the downstream effects of cytosolic 
accumulation of nDNA in RPE cells. Importantly, deletion of STING was able to prevent 
not only the pro-inflammatory cytokines and VEGF, but also the two main cell 




This reveals an important role for STING in mediating cellular senescence and 
other pathological processes that contribute to the development and progression of AMD 





Rapamycin, aging, and AMD … promising, but still challenging.  
 
Rapamycin is an FDA-approved immunosuppressive drug. It was first discovered 
as an antifungal metabolite produced by Streptomyces hygroscopicus from a soil sample 
of Easter Island (also known as Rapa Nui)90,119. Later on, it was discovered that 
rapamycin has immunosuppressive and antiproliferative properties in mammalian cells, 
but its mechanism of action was not known. Then, the target of rapamycin (TOR) was 
identified in yeast and animal cells. Mammalian TOR (mTOR, also known as 
mechanistic TOR) is a kinase that functions in two distinct complexes mTOR complex 1 
(mTORC1) and mTOR complex 2 (mTORC2). Rapamycin forms a complex with 
FK506-binding protein (FKBP12), which then interacts specifically with mTORC1 acting 
as an allosteric inhibitor of its activity90,119.  
mTOR pathway is a key player in longevity regulation and has been found to be 
activated in aging and age-related diseases119. Genetic or pharmacological inhibition of 
mTOR signaling has been shown to extend lifespan of invertebrates and some mammals, 
such as mice119. For instance, Harrison et al. showed that rapamycin extends the lifespan 
of male and female mice when beginning treatment at 9 or 20 months of age (1.5–2 year 
duration)120. Despite some limitations related to study design and analysis, subsequent 
studies clearly confirmed this effect both when rapamycin is administered early or late in 
life, although the effect seems to be more prominent in female mice90,119. While little is 




involvement of mTOR pathway in RPE senescence in vitro and suggested this pathway 
as a potential therapeutic target in AMD121,122.  
Activation of mTORC1 in RPE cells with cytosolic accumulation of nDNA and 
the ability of rapamycin to prevent the phenotypes resulting from this accumulation 
supports the role of mTOR in age-related diseases, including AMD, and suggests that 
rapamycin could potentially be used to inhibit the downstream effects induced by 
cytosolic accumulation of nDNA in RPE cells, and thus to delay the progression of 
AMD. The ability of rapamycin to inhibit the effects of cytosolic accumulation of nDNA 
on the retina in vivo should be evaluated in future studies.  
Long-term clinical studies are needed to evaluate the anti-aging benefits of 
rapamycin. However, this will be challenging considering that the patent of this drug has 
run out (i.e., no company is motivated to invest in a human trial) and that long-term use 
of rapamycin has yielded modest outcomes in the clinic when tested for some tumors90,119 
due to multiple reasons. First, there are serious side effects for long-term use of 
rapamycin, such as thrombocytopenia, hyperlipidemia, impaired wound healing, 
nephrotoxicity, and altered insulin sensitivity119. Although it does not directly inhibit 
mTORC2, chronic exposure to rapamycin can sequester mTOR from mTORC2, 
inhibiting mTORC2 assembly. This is thought to contribute to the metabolic side effects 
associated with long-term use of rapamycin90,119. Second, rapamycin surprisingly fails to 
completely inhibit some mTORC1-mediated processes119. Third, the presence of many 
feedback loops and compensatory pathways that crosstalk to mTOR signaling90,119. While 




including combination therapy that includes rapamycin, intermittent use of rapamycin (to 
relieve mTORC1 from the chronic inhibition, which showed promising results), and the 
design of better inhibitors of mTOR singling, more efforts and studies are still needed to 
achieve the goal of extending lifespan by manipulating mTOR signaling.  
The interaction between STING and mTOR pathway that was recently reported in 
immune cells exposed to DNA viruses89 and that we observed in RPE cells with cytosolic 
accumulation of endogenous self-nDNA further advances our knowledge about the link 
between sensing nDNA, cell senescence, and, probably, age-related diseases. Further 
studies are needed to fully understand the role of this communication in physiological 





Animal models of AMD … strengths and limitations  
 
Developing an accurate model for AMD can assist greatly in understanding the 
disease pathophysiology and discovering effective therapies. The ideal AMD model 
should be inexpensive, recapitulate the histological and functional abnormalities, and 
evolve in a rapid time course to allow more efficient studies123. While models of AMD 
have been created in mice, rats, rabbits, pigs, and non-human primates, rodents are still 
the preferred species because of their low cost, they develop the disease in a relatively 
short time, and the ability to perform genetic manipulation on them123. Although these 
models mimic many of AMD pathological features, none of them develop all the 
characteristics of the disease and developing a perfect model of AMD has been 
challenging due to many obstacles. First, AMD is a complex multifactorial disease that 
has both genetic and environmental risk factors, including numerous genetic 
polymorphisms, oxidative stress, inflammation, lipid and carbohydrate metabolism, and 
others. Second, the anatomical differences of the retina between the species used for 
AMD models and humans. For instance, rodents, the preferred models to use, do not have 
an anatomical macula123,124.  
Most rodent models of dry AMD have been developed through genetically 
manipulating some of the main pathological processes involved in AMD, especially 
inflammation (mainly genes of the complement factor pathway and chemokines), 
oxidative stress, and lipid and glucose metabolism123,124. Models of wet AMD have been 




of growth factors that induce neovascularization123,124. Figure 26 shows a summary of the 
current models of dry and wet AMD, the approach used to generate them, and the main 
AMD characteristics they develop123. Our model of cytosolic accumulation of nDNA 
through conditional deletion of Dnase2a shows aberrant regulation of more than one 
biological processe involved in AMD and mimics most of the disease characteristics, 
including thickened BM, sub-RPE and subretinal deposits, RPE damage and atrophy, 
increased autofluorescence, immune cell accumulation, photoreceptor atrophy, and 
reduced electroretinogram. Therefore, this model not only confirms the importance of 
cytosolic accumulation of nDNA in AMD pathogenesis, but also can be used as a model 
the recapitulates most of the disease characteristics and thus could help in testing novel 
















Figure 26. Current models of AMD. Summary of the current models of dry and wet 
AMD, the approach used to generate them, and the main AMD characteristics they 






Inducing the deletion of Dnase2a in adult mice in our model allows us to avoid 
any confounding phenotypes due to deletion of Dnase2a during development. A main 
limitation, however, is that he Dnase2a knockout is systemic, not specific to the RPE or 
the photoreceptors.  Therefore, the observed retinopathy may not be only due to the local 
cytosolic accumulation of nDNA in the retina. Instead, contribution of the systemic 
accumulation of nDNA to the observed retinopathy is still a possibility. Indeed, it is 
important to realize that AMD can be considered a part of or a manifestation of a 
systemic disease and that it has multiple systemic risk factors. Hence, our results from 
systemic Dnase2a knockout mice are still important for the understanding of AMD 
pathophysiology. Due to technical limitations, generating and studying RPE- and 







In summary, this study has uncovered a contribution of cytosolic nDNA 
fragments to an age-related disease via induction of multiple mechanisms, including RPE 
cell senescence, pro-inflammation, and VEGF secretion, which can be prevented by 
blocking the sensor that senses this DNA. In addition to shedding light on the 
mechanisms of the pleiotropic effects of cytosolic nDNA accumulation, this study 
suggests that targeting this process can be a new potential therapeutic approach for 
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2014-present   Boston University School of Medicine, Boston, MA  
PhD in biomedical sciences (experimental pathology).  
• PhD research is performed at Massachusetts Eye and Ear, Harvard 
Medical School 
• Thesis topic: The role of cytosolic accumulation of nuclear DNA fragments 
in the pathogenesis of Age-related Macular Degeneration (AMD) 
 
2013-2017       Northeastern University, Boston, MA                                                             
Master of Public Health (MPH), magna cum laude 
 
2011-2014       Massachusetts Eye and Ear, Harvard Medical School, Boston, MA                           
Research fellowship in the field of retina research  
 
2004-2010       Faculty of Medicine - Damascus University, Damascus, Syria                                  
Doctor of Medicine (MD) 
 
2001-2004       “Al-Saadah” High School, Damascus, Syria                                                             
Baccalaureate in Science (Honor degree) 
 
2013                Educational Commission for Foreign Medical Graduates (ECFMG) certified     
 United States Medical Licensing Examination (USMLE):  
• 2010  Passed the USMLE Step2 CK exam                                                        
• 2011  Passed the USMLE Step1 exam                                                               
• 2013  Passed the USMLE Step2 CS exam  
• 2017  Passed the USMLE Step3 exam                                                      
	
Other	Educational	Experiences	and	Certificates		
10/2016-01/2017  Fellow, Massachusetts Institute of Technology (MIT) IMPACT Intensive, 
Cambridge, MA  
• Program for career development for post-doctoral and advanced pre-
doctoral trainees.  
                       
06/2016                Certificate, Johns Hopkins Teaching Institute, Baltimore, MD  
• 3 day teaching institute offered by Johns Hopkins Teaching Academy to 
doctoral students and post-docs to advance the development of university-level 
educators by enhancing classroom teaching skills.   
 




• Semester-long course designed to help graduate students and postdocs learn 
how to design and run an effective online course. Offered by the NSF Center 
for the Integration of Research, Teaching, and Learning (CIRTL). 
 
10/2013               Certificate, Introduction to Clinical Investigation course, Harvard Catalyst, 
Boston, MA  
• Five day intensive course providing an overview of the types of clinical 
translational research. 
                                                                             
Clinical Electives, Activities and Work 
06-08/2017        12 wk rotation in Cornea Dept. (with Dr. James Chodosh) at Mass. Eye and Ear, 
HMS, Boston, MA.    
 
 
05/2014-present Observe frequently in the clinics of Retina Dept. (with Dr. Dean Eliott) at Mass. 
Eye and Ear, HMS, Boston, MA. 
                            
2012-present      Attend weekly grand rounds, resident lecture series, and the clinical macula 
conference at Mass. Eye and Ear, HMS. 
 
03/2011-09/2011 General Practitioner at Al-Mahaini Hospital, Damascus, Syria. 
 
12/2010-01/2011 8 wk rotation in Cornea (with Dr. Reza Dana), Retina and Comprehensive 
Ophthalmology departments at Mass. Eye and Ear, HMS, Boston, MA. 
 
11/2010         4 wk rotation in Pediatric Ophthalmology and Strabismus (with Dr. Sharon Freedman), 
Retina and Comprehensive Ophthalmology Departments at Duke Eye Centre, 
Duke University, North Carolina. 
 
03/2010               4 wk elective in Ophthalmology Dept., American University of Beirut Medical 
Center, Lebanon. 
 
08/2008               4 wk elective, Oxford Eye Hospital, Oxford Univ. Oxford City, UK. 
 
07/2008               4 wk elective, Internal Medicine Dept., John Radcliffe Hospital, Oxford 
University, Oxford City, UK. 
		
Research	Experience	
Basic and Translational Research: 
 
Skills used in the following projects include many lab techniques, such as cell culture of cell lines, 
primary cells, and stem cells, western blot, qRT-PCR, ELISA, immunoprecipitation, co-
immunoprecipitation, immunohistochemistry, immunocytochemistry, flow cytometry, different 
molecular biology techniques (e.g., cloning, mini-prep, and maxi-prep), different gene knockout 
technologies (e.g., siRNA, shRNA, CRSIPR-Cas9) and handling lab mice.        
 
2014-present     PhD candidate at Angiogenesis Laboratory, Massachusetts Eye and Ear  
                          Supervisors: Demetrios Vavvas, MD, PhD and Haijiang Lin, MD, PhD  
 
• Project 1: The role of cytosolic accumulation of nuclear DNA fragments in 




Use primary Retinal Pigment Epithelial (RPE) cells isolated from both AMD 
and healthy control postmortem eye globes, a mouse model of accumulation of 
nuclear DNA, and a genetically-edited RPE cell line to study the presence and 
consequences of nuclear DNA accumulation in RPE cells and its relation with 
the development and progression of AMD.  
 
• Project 2: The effect of atorvastatin on the inflammatory response and 
phagocytosis of human RPE cells.    
Study the possible mechanisms by which statins exert their therapeutic effect 
against AMD by studying the protective effects of atorvastatin on the 
inflammatory response and the impairment of phagocytosis that is induced by 
cholesterol crystals and oxidized-LDL in RPE cells. 
 
• Project 3: The role of the necroptosis kinases in the induction of induced 
pluripotent stem cells (iPSCs) from fibroblasts.  
The detailed mechanisms of reprogramming somatic cells to iPSCs are still 
mostly unknown. The purpose of this project is to study the effects of Receptor-
interacting Kinases 1 and 3 (RIP1 and RIP3), two essential kinases in necroptosis 
pathway: a main cell death mechanism, on the induction of iPSCs from mouse 
embryonic fibroblasts (MEFs).   
 
2011-2014         Postdoctoral research fellow at Angiogenesis Laboratory, Massachusetts Eye and 
Ear  
and Pediatric Surgery Laboratory, Massachusetts General Hospital, Harvard 
Medical School                         
                          Supervisors: Demetrios Vavvas, MD, PhD and Patricia Donahoe, MD 
 
• Project 1: The effects and mechanism of aminoimidazole carboxamide 
ribonucleotide (AICAR), an AMP-dependent kinase (AMPK) activator, on 
the growth of uveal melanoma cells. 
The purpose of this project was to evaluate the effects of AICAR, an AMPK 
activator that has low toxicity, as a potential novel targeted therapy for uveal 
melanoma.   
 
• Project 2: The effects of the clinically used photosensitizer Verteporfin on 
YAP-TEAD pathway and the growth of both human retinoblastoma and 
optic nerve glioma cells without using light activation. 
The purpose of this project was to evaluate a novel non light-dependent effect of 
verteporfin on the growth of some interocular tumor cells, specifically 
retinoblastoma and optic nerve glioma, through disrupting the YAP-TEAD 
signaling pathway.   
 
• Project 3: The role of light in verteporfin-induced formation of protein 
cross-linked oligomers and high molecular weight complexes. 
The purpose of this project was to carefully look at the role of light and darkness 
in some cellular effects of verteporfin, which have likely been mistakenly 






• Project 4: The regulatory role of AMP-dependent kinase (AMPK) on the 
expression of C-C chemokine receptor 2 (Ccr2) in RAW264.7 Macrophages. 
The purpose of this study was to assess AMPK’s role in regulating RAW264.7 
macrophage Ccr2 protein levels in resting (M0) or LPS-induced M1 states to 
better understand the inflammatory response.  
 
• Project 5: Developing a novel method to enhance the preparation and 
purification of Mullerian Inhibiting Substance (MIS), detect its receptor, 
and discover its unknown signaling pathways with using this method to 
study the role of MIS in ocular angiogenesis and retinal neuroprotection. 
The purpose of this project was to develop a novel method for producing pure 
recombinant MIS, by adding a FLAG-tag and an albumin leader sequence 
coupled with a cleavage site modification, and then using this recombinant 
protein to detect MIS receptor in retinal microvascular endothelial cells and the 
neuroretina and study its role in angiogenesis and retinal neuroprotection.    
 
Clinical and Public Health-related Research:  
 
08/2016-05/2017     Massachusetts Eye and Ear. Supervisor: Brian Song, MD, MPH 
• Assess the patterns of glaucomatous visual field (VF) loss associated 
with diabetes status and other correlates using computationally-
derived visual field archetypes. 
Using a large dataset (2150 patients) of VF archetypes generated using 
Archetypal Analysis, the purpose of this study was to investigate the 
association between certain VF archetypes, which represents peripheral and 
paracentral VF loss, and diabetes status to determine if the presence of 
diabetes, or other factors, affect the phenotypic presentation of VF loss in 
patients with glaucoma. 
 
07/2014-05/2015     Massachusetts Eye and Ear. Supervisor: James Chodosh, MD, MPH 
• Evaluating the outcomes of an algorithmic approach to treating mild 
ocular alkali burns to standardize the treatment of acute ocular alkali burns 
at the MEEI Emergency Department. 
 
05/2015-06/2015    Massachusetts Eye and Ear. Supervisor: James Chodosh, MD, MPH 
• Evaluating the outcomes of Boston type I keratoprosthesis implanted in 
elderly patients including best-corrected visual acuity (BCVA), device 
retention and complication rates, in patients >75 years old at the time of 
surgery. 
 
2009-2013              Ophthalmology Department, American University of Beirut Medical Center, 
Beirut, Lebanon. 
Supervisor: Christiane Al-Haddad 
• Assessing fornix-based versus limbal-based conjunctival 
trabeculectomy flaps for glaucoma. 
The purpose of this Cochrane systematic review is to assess the comparative 




trabeculectomy for adult glaucoma, with a specific focus on intraocular 
pressure (IOP) control and complications (adverse effects). 
Publications 
 * Co-first author.   ** Corresponding author  
• Al-Moujahed A., Tian B., Miller J. W., Lan Y.Y., Vavvas D., Lin H. Cytosolic accumulation of 
nuclear DNA (nDNA) fragments contributes to the pathogenesis of Age-related Macular 
Degeneration (AMD). To be submitted.  
 
• Al-Moujahed A., Tian B., Konstantinou E., Hoang M., Efstathiou N., Lin H., Miller J. W., 
Vavvas D. Receptor interacting protein kinase 3 (RIP3) regulates iPSCs generation through 
modulating cell cycle progression genes. Under review: Stem Cell Research. 
• Kalevar A., Agarwal, Al-Moujahed A., Eliott D. Cerebral Cavernous Malformation with Retinal 
Lesions: Case Series of 3 Families. To be submitted to Retina. 
 
• Al-Moujahed A., Moledina A., Elze T., Pasquale L. R., Song B. J. (2017) Patterns of 
glaucomatous visual field loss associated with diabetes status and other clinical correlates using 




• Turk T., Al-Saadi T., Alkhatib M., Hanafi I., Alahdab F., Firwana B., Koudsi M., Al-Moujahed 
A. (2017) Attitudes, Barriers, and Practices Towards Research and Publication among Medical 
Students at the University of Damascus, Syria. Avicenna J Med 2018; 8(1):24-33 
 
• Al-Moujahed A., Brodowska K.., Stryjewski T., Efstathiou N., Vasilikos, I., Cichy J., Miller J. 
W., Gragoudas E., Vavvas D. (2017) Verteporfin inhibits growth of human glioma in vitro 
without light activation. Sci Rep 7:7602 
 
• Sabouni A., Chaar A., Bdaiwi Y., Masrani A., Abolaban H., Alahdab F., Al-Moujahed A.** 
(2017) American physicians helping Syrian doctors find their voice: Online publication skills and 
academic writing course. Avicenna J Med  2017;7:103-9. 
 
• Abolaban H., Al-Moujahed A. (2017) Muslim Patients in Ramadan: a Review for Primary Care 
Physicians. Avicenna J Med  2017;7:81-7.  
 
 
• Tian B., Al-Moujahed A.*, Bouzika P., Hu Y., Notomi S., Tsoka P., Miller J. W., Lin H., Vavvas 
D. (2017) Atorvastatin Promotes Phagocytosis and Attenuates Pro-Inflammatory Response in 
Human Retinal Pigment Epithelial Cells. Sci Rep  7: 2329 
 
• Konstantinou, E. K., Notomi, S., Kosmidou, C., Brodowska, K., Al-Moujahed, A., Nicolaou, F., 
Tosca P., Gragoudas E., Miller J.W., Young L. H., Vavvas D. (2017) Verteporfin-induced 
formation of protein cross-linked oligomers and high molecular weight complexes is mediated 
by light and leads to cell toxicity. Sci Rep 7:46581  
 
• Al-Moujahed A**, Alahdab F, Abolaban H, Beletsky L. (2017). Polio in Syria: problem still not 





• Alahdab F., Al-Moujahed A., Firwana B., Diab M., Masrani A., Sankari A., Arabi M., Atassi B., 
Arabi H., Chaar A. (2017). Re: Quality of care delivered by general internists in US hospitals 
who graduated from foreign versus US medical schools: observational study. BMJ 356:j273 
 
• Alahdab F., Alabed S., Al-Moujahed A., Al-Sallakh M. A., Alyousef T., Alsharif U., Fares M., 
Murad M.H. (2017) Evidence-based medicine: a persisting desire under fire. Evid Based Med-
BMJ 22(1), 9–11.  
 
• Al-Haddad C., Abdulaal M., Al-Moujahed A., Ervin A., Ismail K. (2017) Fornix-based versus 
Limbal-based Conjunctival Trabeculectomy Flaps for Glaucoma: Findings from a Cochrane 
Systematic Review. Am J Ophthalmol Feb;174:33-41 
 
• Homayounfar, G., Grassi, C. M., Al-Moujahed, A., Colby, K. A., Dohlman, C. H., Chodosh, J. 
(2016). Boston keratoprosthesis type I in the elderly. Br J Ophthalmol Apr;101(4):514-518. 
 
• Kumase F., Takeuchi K., Morizane Y., Suzuki J., Matsumoto H., Kataoka K., Al-Moujahed A., 
Maidana D.E., Miller J.W., Vavvas D.G. (2016). AMPK-Activated Protein Kinase Suppresses 
Ccr2 Expression by Inhibiting the NF-κB Pathway in RAW264.7 Macrophages. PloS One Jan 
22;11(1). 
 
• Arabi M., Atassi B., Masrani A., Alahdab F., Al-Moujahed A., Arabi H. (2016) Avicenna Journal 
of Medicine: 5-year milestones. Avicenna J Med Jan-Mar;6(1):1-2 
 
• Al-Haddad C., Abdulaal M., Al-Moujahed A., Ervin AM. (2015) Fornix-based versus limbal-
based conjunctival trabeculectomy flaps for glaucoma. Cochrane Database of Systematic 
Reviews Nov 25;(11):CD009380 
 
• Al-Moujahed A., Chodosh J. (2015) An algorithmic approach improves outcomes in mild ocular 
alkali burns. JAMA Ophthalmol Oct;133(10):1214-6. 
 
• Alahdab F., Omar M., Alsakka S., Al-Moujahed A., Atassi, B. (2014). Syrians  alternative to a 
health care system: “field hospitals.” Avicenna J Med Jul;4(3):51-2. 
 
• Brodowska, K., Al-Moujahed, A., Marmalidou, A., Meyer Zu Horste M., Cichy J., Miller J.W., 
Gragoudas E., Vavvas D.G. (2014). The clinically used photosensitizer Verteporfin (VP) inhibits 
YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. Exp Eye Res 
Jul;124:67-73 
 
• Al-Moujahed A., Nicolaou F., Brodowska K., Papakostas T.D., Marmalidou A., Ksander B.R., 
Miller J.W., Gragoudas E., Vavvas D.G. (2014) Uveal melanoma cell growth is inhibited by 
amino- imidazole carboxamide   ribonucleotide (AICAR) partially through activation of AMP-
dependent kinase. Invest Ophthalmol Vis Sci. Apr 29;55(7):4175-85 
 
• Pépin D., Hoang M., Nicolaou F., Hendren K., Benedict L. A., Al-Moujahed, A., Sosulski A., 
Marmalidou A., Vavvas D., Donahoe P.K. (2013). An albumin leader sequence coupled with a 
cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting 
Substance. Technology Sep;1(1):63-71. 
 




05/2018      The Association for Research in Vision and Ophthalmology (ARVO). Presentation. 
 
• Damaged nuclear DNA accumulates in retinal pigment epithelium cells of age-
related macular degeneration patients. 
                   Haijiang Lin, Bo Tian, Ahmad Al-Moujahed, Joan W. Miller, Demetrios G. Vavvas. 
  
01/2017      Ann W. Caldwell President’s Lecture, MGH Institute of Health Professions. Invited 
speaker.  
 
• “Caring for Our Muslim Patients”. Invited speaker, with Heba Abolaban, MD, MPH 
and Robert P. Marlin, MD, PhD, MPH. The Interprofessional Rounds at MGH 
Institute of Health Professions is an annual event in which second-year students in 
the entry-level graduate programs come together to hear successful examples of how 
clinical teams collaborate to provide patient-centered care. 
 
05/2017      The Association for Research in Vision and Ophthalmology (ARVO). Presentation. 
 
• Verteporfin-induced formation of protein oligomers is mediated by light and leads 
to cell toxicity 
Eleni Konstantinou, Shoji Notomi, Katarzyna Brodowska, Ahmad Al-Moujahed, 
Fotini Nicolaou, Pavlina Tsoka, Evangelos S. Gragoudas, Joan W. Miller, Lucy 
Young, Demetrios G. Vavvas. 
 
05/2014      The Association for Research in Vision and Ophthalmology (ARVO). Presentation. 
 
• Verteporfin (VP) inhibits human retinoblastoma cell growth in vitro without light 
activation 
Katarzyna Brodowska, Ahmad Al-Moujahed, Anna Marmalidou, Melissa Meyer zu 
Horste, Joanna Cichy; Joan W Miller, Evangelos S Gragoudas, Demetrios Vavvas. 
 
05/2013      The Association for Research in Vision and Ophthalmology (ARVO). Presentation. 
 
• Uveal Melanoma Cells Are Inhibited by Aminoimidazole Carboxamide 
Ribonucleotide (AICAR) Partially through Activation of AMP-Dependent Kinase 
Ahmad Al-Moujahed, Fotini Nicolaou, Thanos Papakostas, Joan Miller, Evangelos 
Gragoudas, Demetrios Vavvas. 
 
Posters at National Conferences  
05/2018       The Association for Research in Vision and Ophthalmology (ARVO). 
 
• The role of necroptosis kinases in the induction of iPSCs from fibroblasts. 
                       Ahmad Al-Moujahed, Bo Tian, Eleni Konstantinou, Haijiang Lin, Demetrios G. 
Vavvas. 
 
10/2017       The Annual Retina Society Meeting.  
 
• Cerebral Cavernous Malformation with Retinal Lesions: case series of 3 families.  
                   Kalevar A., Agarwal , Al-Moujahed A., Papakostas T., Eliott D. 
 





• Absent in Melanoma 2 (AIM2) recognizes cytosolic DNA and mediates 
inflammation in human retinal pigment epithelial cells.  
   Ahmad Al-Moujahed, Bo Tian, Joan W. Miller, Haijiang Lin, Demetrios G. 
Vavvas. 
 
• Accumulation of damaged nDNA promotes RPE cellular senescence and pro-
inflammation.  
Haijiang Lin, Bo Tian, Ahmad Al-Moujahed, Joan W. Miller, Demetrios G. 
Vavvas. Recognized as “Hot  topic poster” 
 
• Atorvastatin promotes phagocytosis and attenuates pro-inflammatory response in 
human retinal pigment epithelial cells.  
Bo Tian, Ahmad Al Moujahed, Peggy Bouzika, Yijun Hu, Shoji Notomi, Pavlina 
Tsoka, Joan W. Miller,  Haijiang Lin, Demetrios G. Vavvas. 
 
05/2016       The Association for Research in Vision and Ophthalmology (ARVO). 
 
• Verteporfin inhibits growth of human ocular glioma in vitro without light 
activation.  
Ahmad Al-Moujahed, Katarzyna Brodowska, Tomasz Stryjewski, Joanna Cichy, 
Evangelos S Gragoudas,  Demetrios Vavvas. 
 
05/2015       The Association for Research in Vision and Ophthalmology (ARVO).  
 
• Deferoxamine inhibits the growth of uveal melanoma cells In Vitro.  
Thanos D Papakostas, Fotini Nicolaou, Ahmad Al-Moujahed, John B Miller, 
Haijiang Lin, Evangelos S Gragoudas, Demetrios Vavvas. 
 
05/2013       The Association for Research in Vision and Ophthalmology (ARVO).  
 
• Evidence for baseline abnormalities in the retinal vascular network of Trp1-Cre 
mice.  
   Aristomenis Thanos, Ahmad Al-Moujahed, Lucy Young, Demetrios Vavvas. 
 
05/2013       Mass. General Hospital Research Fellow Poster Celebration Day. 
 
• Uveal Melanoma Cells Are Inhibited by Aminoimidazole Carboxamide 
Ribonucleotide (AICAR) Partially through Activation of AMP-Dependent Kinase.  
Ahmad Al-Moujahed, Fotini Nicolaou, Thanos Papakostas, Joan Miller, Evangelos 
Gragoudas, Demetrios Vavvas. 
 
 
Editorial Service   
2015-present      Assistant Editor - Avicenna Journal of Medicine  
2015-present      Ad Hoc reviewer - PLoS One  
2015-present      Ad Hoc reviewer - Avicenna Journal of Medicine  
 
Teaching Experience 
09/2016-01/2018   Online Journal Club (designer of the program, panelist, and organizer) 




• An online journal club in Arabic to enhance the knowledge and practice of 
evidence-based medicine in Syria and the Middle East through live discussions 
of clinical research papers. Planned all activities for the journal club by inviting 
speakers, moderating the sessions, and then giving the opportunity to younger 
volunteers to lead the project.  
 
10-11/2015          Academic Writing in Medicine online course (director and lecturer)                
 
• A 12-lecture online course, in Arabic, designed to teach medical students and 
healthcare professionals in Syria and the Middle East the principles of academic 
writing and publishing using basic social media platforms for recording the live 
sessions, uploading the videos of the lectures, and holding after-class 
discussions. > 2,000 students joined the course; 200 completed at least 10 of the 
12 sessions.  
• Designed the curriculum, invited speakers, taught in both the online sessions 
and through social media group discussions, and coordinated logistics between 
the volunteers.  
• This experience and its results were written and published in the Avicenna 
Journal of Medicine. 
 
02-04/2015          Evidence-Based Medicine (EBM) online course (organizer and lecturer)                     
 
• A 17-lecture online course, in Arabic, designed to teach medical students and 
healthcare professionals in Syria and the Middle East the principles of evidence-
based medicine using similar technologies to the course mentioned above.  
• Taught online sessions and utilized social media discussion group and 
coordinated the logistics.  
• This experience and its results were published in the Evidence Based Medicine-
BMJ under the title “Evidence-based medicine: a persisting desire under fire” 
and was featured as an editor’s choice and is among the most 5 popular papers 
on the journal. 
 
2009 and 2010    Essentials of Evidence-Based Medicine course. Faculty of Medicine, Damascus 
University, Syria.      
                            (organizer and lecturer) 
 




2013-present                Member of the Association for Research in Vision and Ophthalmology 
(ARVO). 
2010-present                Member of the Syrian American Medical Society (SAMS). 
 
Honors, Awards, and other Certificates 
05/2017             Recognized as an outstanding student at Northeastern University in 2017.  
 
11/2014             Nicholas Skala Student Scholarship to Physicians For a National Health 





09/2013             Dean’s Scholarship from Bouvé College of Health Sciences Master of Public 
Health program,   Northeastern University.  
 
11/2004             Honor award for excelling in Baccalaureate of Science. 
 
 
	
